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Plasma membrane maintenance in muscular dystrophy and the role of dysferlin-
mediated membrane repair in skeletal muscle. 
 
Muscular dystrophy and plasma membrane integrity: 
Muscular dystrophy:  The muscular dystrophies are a diverse group of inherited muscle 
wasting disorders that affect skeletal muscle and/or cardiac muscle resulting from 
mutations in >30 different genes [1]. Common pathological features include cycles of 
degeneration and regeneration, infiltration of immune cells, fibrosis, and fatty infiltrate 
within the muscle; all of which compromise muscle function [1]. Patients with muscular 
dystrophy typically succumb to respiratory failure as a result of impaired diaphram 
function or cardiac failure [2]. Proteins implicated in muscular dystrophy play a wide 
variety of cellular roles, including cell-ECM interactions [3-5], cytoskeletal organization 
or function [6], sarcomeric organization [7], and membrane trafficking [8]. Mutations in 
several components of the Dystrophin-glycoprotein complex (DGC), an adhesion 
complex that mediates the functional linkage between the intracellular actin 
cytoskeleton and the extracellular matrix, result in muscular dystrophies (Fig 1-1, 
reviewed in [2]). Although there is no universal cellular mechanism by which genetic 
mutations result in muscular dystrophy, many muscular dystrophies (particularly those 
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associated with the DGC) show marked instability of the plasma membrane that renders 
cells susceptible to cellular wounding [9]. 
 
Maintenance of the plasma membrane is critical and loss of DGC components leads to 
membrane instability and muscular dystrophy: The DGC, is a multi-protein complex that 
links the intracellular F-actin cytoskeleton through the plasma membrane to laminin 
present in the basal lamina. The intracellular linkage to F-actin is mediated by 
dystrophin, a >400 kDa protein that contains an N-terminal actin binding domain, a 
central rod domain and a C-terminal domain that interacts with β-dystroglycan within the 
plasma membrane [10]. Dystroglycan is a membrane spanning protein composed of two 
subunits (α and β) that form as a result of post-translational cleavage of a full length 
precursor protein [11]. Beta dystroglycan contains the transmembrane domain and 
interacts with dystrophin, whereas alpha-dystroglycan is entirely extracellular, is highly 
glycosylated, and mediates the functional linkage with the extracellular matrix through 
its interaction with laminin [11]. Although the exact mechanism whereby mutations in 
DGC components cause muscular dystrophy is not entirely clear, a growing body of 
evidence suggests that loss of the DGC may reduce membrane stability and render 
cells susceptible to membrane wounding. This assertion is supported by the finding that 
muscles from several mouse models of DGC deficiency take up more membrane 
impermeable proteins (IgG) and extracellular dyes (EBD) compared with normal 
muscle. Furthermore, dye uptake into mutant muscles is markedly increased following 
exercise [12, 13]. Furthermore, uptake of extracellular macromolecules into muscle 
fibers is associated with release of muscle-specific cytoplasmic enzyme creatine kinase 
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into the bloodstream [13]. In-vitro, DGC-deficient muscles display reduced force 
generation capacity following lengthening contraction, which has been associated with 
increased tearing of myofibers following contraction [14] and uptake of membrane 
impermeable dyes following contraction induced damage in-vitro [15]. Overall, these 
data support the assertion that genetic mutations (at least within the DGC) cause 
muscular dystrophy by compromising plasma membrane integrity, and highlight the 
critical role for maintenance of the plasma membrane in muscle cells.  
 
Dysferlinopathy and a novel pathway to muscular dystrophy:  
Dysferlin deficiency results in muscle disease: Dysferlin is expressed in most tissues at 
low levels, with highest expression in adult skeletal and cardiac muscle [16, 17]. 
Western blot analysis using an antibody to the dysferlin protein identified a ~220 kDa 
protein highly enriched in membrane fractions from mature cardiac and skeletal muscle 
[16, 18]. Antibody labeling of skeletal muscle in cross section reveals that dysferlin is 
localized to the lateral sarcolemma in muscle biopsies from normal human skeletal 
muscle and is largely absent in biopsies from patients with Limb-girdle muscular 
dystrophy 2B (LGMD2B), Myoshi Myopathy (MM) and Distal myopathy (DM) 
(collectively called dysferlinopathies) [19]. Although secondary loss of dysferlin 
expression has been noted in LGMD patients with mutations in genes other than 
dysferlin [20], the vast majority of dysferlinopathy cases can be attributed to 
homozygous or compound heterozygous mutations spanning the entire dysferlin gene 
[21], resulting in near complete loss of dysferlin expression. LGMD2B, DM and MM vary 
in their clinical presentation, with LGMD2B affecting predominantly the muscles in the 
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limb-girdle, and MM/DM pathology initiating in the distal limb musculature, or a mixed 
“proximodistal” presentation [22]. In some instances divergent phenotypes can result 
from identical mutations within the dysferlin gene, which may result from modifier genes 
or environmental factors such as activity level [19, 23]. Mild cardiac involvement can 
occasionally be detected in dysferlinopathy patients, but overt cardiomyopathy due to 
dysferlin-deficiency is rare [24]. Dysferlinopathy patients share several common 
pathological features with non-dysferlin muscular dystrophies, including, extremely high 
plasma creatine kinase, marked inflammatory infiltration, and progressive muscle 
weakness [22]. In some cases, the inflammatory response is so robust that patients are 
mis-diagnosed as having polymyositis [25]. The age of onset of dysferlinopathy varies 
considerably in humans ranging from the second to the eighth decade of life, which may 
be due to environmental factors such as injury due to physical activity [26]. There is 
currently no effective therapy for dysferlinopathy, as steroid treatments effective in other 
dystrophies are ineffective in dysferlinopathy [27, 28]. Structure-function studies aimed 
at finding the minimal structural domains required for functional dysferlin in muscle are 
currently underway [29], and these functional domains will be described later in this 
chapter. 
 Several mouse models serve as important tools for studying the pathogenesis of 
dysferlinopathy [30]. The two most commonly studied mouse models are the A/J 
mouse, which is a spontaneous mutation in the dysferlin gene due to a retrotransposon 
insertion between exons 4 and 5, resulting in loss of both mRNA and protein expression 
[31]; and the SJL mouse which harbors a splice site mutation, resulting in ~15% 
dysferlin protein expression in skeletal muscle relative to muscles from wild-type mice 
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[32]. Loss of dysferlin in the A/J, SJL, and several targeted knockout mice recapitulates 
several hallmarks of muscle disease in humans including elevated plasma creatine 
kinase, inflammatory infiltration, centrally nucleated fibers, and a small but significant 
number of fibers showing uptake of membrane impermeable Evan's blue dye [31]. 
Analysis of the muscle pathology in SJL compared to A/J mice indicates that the 
pathology is more severe within the SJL mouse. In the SJL mouse pathology begins in 
the proximal muscles at 2 months of age, and progresses to both proximal and distal 
presentation after 5 months of age, whereas presentation of pathology in A/J mice is 
delayed until 5 months of age [31]. Although the pathogenesis of dysferlin-deficiency is 
well described within human dysferlinopathy patients [22] and mouse models [31], the 
exact mechanism by which dysferlin-deficiency results in muscle disease is not clear. 
Recent studies have begun to address this question, and the findings suggest that the 
cellular deficit associated with dysferlin-deficiency may be independent of defective 
membrane stability [18, 33]. 
 
Dysferlin deficiency causes muscular dystrophy via a DGC independent pathway: 
Several independent lines of evidence indicate that dysferlin-deficient muscular 
dystrophy occurs independently of any effects on the DGC and membrane stability (Fig 
1-1). First, dysferlin-deficient mice show normal expression and localization of DGC 
components, and dysferlin is not an integral component of the DGC in normal muscle, 
which argues against a role for dysferlin in membrane stability [31]. Although dysferlin-
deficiency does not affect the DGC, dysferlin is markedly mislocalized away from the 
plasma membrane in a subset of muscle fibers from patients and mice with mutations in 
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DGC components or non-dysferlin LGMDs, indicating that DGC-deficiency or cellular 
wounding as a consequence of DGC-deficiency may alter dysferlin localization and/or 
function [20]. Furthermore, combined loss of dysferlin and dystrophin exacerbates the 
phenotype in dysferlin-null mice, indicating that dysferlin function is critical for 
minimizing the adverse effect of DGC-deficiency in muscle [34]. Although dysferlin null 
skeletal muscles contain significantly more Evans blue dye (EBD) positive fibers than 
control muscle at rest, uptake of EBD is not enhanced by mild exercise in dysferlin-
deficient muscle, in contrast to DGC-null muscle [18, 31]. One hallmark of DGC-
deficient muscle is the susceptibility to contraction-induced damage following 
lengthening contractions, which results in reduced maximal force production (termed 
force deficit) [14, 35]. Dysferlin-deficient muscle does not display a force deficit following 
lengthening contraction, suggesting that loss of dysferlin expression does not render 
skeletal muscle susceptible to contraction induced damage, and arguing against a role 
for dysferlin in membrane stability [33]. However, administration of lengthening 
contractions sufficient to injure normal muscle results in delayed force recovery in 
dysferlin-deficient muscle, and recovery of muscle function in dysferlin-null muscle 
requires myogenesis [36], indicating that dysferlin may play a role in the cellular 
response to wounding. Overall, these findings indicate that dysferlin-deficiency 
produces a dystrophic phenotype independent of any effects on the DGC and plasma 






What is the role of dysferlin in muscle cells?: 
Ferlins are evolutionarily conserved mediators of membrane fusion: The dysferlin gene 
encodes a type 2 transmembrane protein with high homology to the ferlin family of 
proteins (Fig 1-2A) [37]. Ferlin proteins are evolutionary conserved mediators of 
membrane fusion across a wide variety of species and cell types [38, 39]. For example, 
mutations in Fer-1, the sole C. Elegans ferlin protein result in sterililty due to impaired 
fusion of the membranous organelle with the spermatid plasma membrane [40]. 
Mutations in otoferlin, a ferlin expressed in the inner ear of mammals results in 
hereditary deafness, due to impaired electrical transmission as a result of impaired 
fusion of synaptic vesicles within inner hair cells [41]. Dysferlin contains 7 putative C2 
domains (C2A-C2F) and a single transmembrane domain toward the extreme C-
terminus, resulting in a long cytoplasmic C2-domain containing N-terminal domain, and 
a short extracellular or luminal domain [38] (Fig 1-2B). The lipid binding ability of C2 
domains within dysferlin have been characterized using in-vitro lipid binding assays, 
which revealed that the C2A domain of dysferlin binds lipids in a calcium-dependent 
manner, while the remaining C2 domains bind lipids independently of calcium [42, 43]. 
The C2A domains of dysferlin, myoferlin and otoferlin are capable of inducing 
membrane curvature in liposomes in-vitro [43]. Interestingly, the C2 domains of dysferlin 
show preferential binding with the types of lipids enriched on the inner leaflet of the 
plasma membrane [42]. Although the exact cellular function that is disrupted in 
dysferlin-deficient muscle that is causal for muscle disease is not entirely clear, these 
findings strongly support a role for dysferlin in mediating membrane binding/fusion 




Potential cellular roles for dysferlin: Consistent with structural and biochemical 
evidence, dysferlin has been implicated in a wide variety of cellular processes related to 
membrane fusion in both muscle and non-muscle cells. In monocytes, dysferlin 
expression is increased during differentiation, and dysferlin deficient monocytes display 
enhanced migration, potentially due to altered integrin trafficking [44]. In endothelial 
cells, loss of dysferlin leads to altered cell adhesion due to increased degradation of a 
critical signaling molecule PECAM [45].  Dysferlin-deficient mice show impaired skeletal 
muscle regeneration following toxin-induced or lengthening contraction-induced 
wounding, which is consistent with in-vitro findings that dysferlin-deficiency impairs cell-
cell fusion of myoblasts [33, 46, 47]. Consistent with a role for dysferlin in membrane 
trafficking, skeletal muscle hypertrophy following insulin-like growth factor (IGF) infusion 
is impaired in dysferlin-null mice potentially due to defective trafficking of the IGFR in 
skeletal muscle cells [48]. Dysferlin may play a role in development and maintenance of 
the transverse tubules, as dysferlin colocalizes with the transverse tubules in developing 
and regenerating muscle in mice [46], differentiating myotubes in-vitro [49], and 
transverse tubule morphology is altered in dysferlin-deficient mice [50]. Perhaps the 
most intensively studied cellular role for dysferlin is in the evolutionarily conserved 
process of membrane repair [18, 49, 51-53]. Given that membrane damage is frequent 
in mechanically active tissues such as muscle [12], the role of dysferlin in membrane 
repair in normal muscle and potential adverse effects of dysferlin-deficiency on 
membrane repair is an area of intense investigation (which will be covered in 
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subsequent sections), but, at present much of what is known about the mechanism of 
membrane repair comes from non-muscle model systems.  
 
Membrane repair in non-muscle model-systems:  
Membrane repair is a critical, evolutionarily conserved process by which cells withstand 
wounding to the plasma membrane:  Membrane repair is a critical process by which 
cells are able to withstand even the most severe wounds to the plasma membrane    
(Fig 1-3A) Capacity to reseal the plasma membrane has been documented across a 
variety of cell types in-vivo including epithelial cells [54], intestinal endothelial cells [55], 
neurons [55-60], cardiomyocytes [61] and skeletal muscle cells [12]. Although the 
causative agent for membrane damage likely depends on the specific cell type in 
question, mechanical wounding [58-60], and exposure to bacterial toxins [62] are likely 
the most common. Several laboratory models of membrane damage have been 
developed to assess membrane repair in-vitro, including detergent permeabilization 
[51], and electroporation [63].  Currently in the field, mechanical wounding using finely 
pulled patch pipettes, and laser-induced wounding typically touted in combination with 
live cell imaging represent the gold standard assays for membrane repair, given that 
individual cells can be studied in real-time following wounding at a specific location on 
the plasma membrane [18, 61, 64]. Using these gold standard injury techniques, several 
independent methods have been employed to quantify membrane resealing in-vitro, and 
these vary from measuring changes in membrane tension [65], and influx of membrane 
impermeable dyes following wounding [18]. Analyzing uptake of FM1-43 (a membrane 
impermeable dye that is fluorescent upon contact with membranes but cannot pass 
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through the plasma membrane) following laser-induced wounds using confocal 
microscopy has emerged as the most commonly used metric of membrane repair [18, 
61, 66, 67] (Fig 1-3B).  
 Most of the mechanistic understanding of how cells repair wounds in the plasma 
membrane comes from studies in non-muscle model systems including sea urchin eggs 
[64, 68-70], neurons [37, 56-60], and fibroblasts [71-73]. Although the mechanism by 
which various cell types reseal the plasma membrane may vary, resealing in most cell 
types requires directed transport of intracellular vesicles toward lesions and calcium-
induced vesicle-vesicle and vesicle-membrane fusion. 
 
Exocytosis, endocytosis, and vesicle-vesicle fusion is critical for membrane resealing: 
Early studies into membrane resealing were prompted by the finding that erythrocytes 
spontaneously reseal following osmotic shock [74]. In erythrocytes, "resealing" occurs 
due to passive interactions between the hydrophobic membrane and aqueous solution 
[74]. In nucleated cells, which have a more elaborate cytoskeletal architecture and 
endure more severe physiological wounds, resealing requires calcium activated vesicle-
vesicle and vesicle-membrane fusion [60, 68, 69, 75, 76]. A role for damage-induced 
exocytosis in membrane resealing was definitively shown in early studies using the sea 
urchin egg, which contain thousands of vesicles docked at the plasma membrane [64]. 
Following wounding, these "docked" vesicles fuse with each other and remaining 
portions of intact plasma membrane to facilitate membrane resealing [64]. Sea urchin 
eggs undergoing larger lesions (~400 um2) reseal due to a dramatic vesicle-vesicle and 
vesicle-plasma membrane fusion response near the lesion [70]. Electron micrographs of 
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sea urchin eggs immediately following large wounds confirmed the presence of a dense 
network of vesicles undergoing vesicle-vesicle fusion, which, at later time points appear 
as a large relatively protein free "plug" spanning the entire lesion [75]. Damage-induced 
exocytosis of docked vesicles in sea urchin eggs is depends on SNARE complexes, as 
cleavage with toxins specific for these interactions impair exocytosis and inhibit 
resealing [64]. Although studies in the urchin egg directly demonstrates a role for 
exocytosis of vesicles in membrane resealing, virtually all cell types lack cortically 
docked vesicles, calling into question whether all cell types utilize an analogous 
mechanism. Subsequent analysis of resealing in fertilized urchin embryos (which lose 
the docked vesicle population as a result of fertilization) have shown that membrane 
wounding activates transport of intracellular vesicles toward the membrane lesion via 
the cytoskeleton and can be separated into kinetically distinct waves of exocytosis [77]. 
Vesicles are delivered along microtubules by kinesin motors until the vesicles reach 
cortical actin, whereby non-muscle myosin-II transports the vesicles toward the plasma 
membrane for their subsequent fusion; disruption of either step reduces damage-
induced exocytosis and impairs resealing [77]. Fibroblasts and other mammalian cell 
types reseal the plasma membrane via an exocytotic mechanism, and the intracellular 
membranes primarily involved appear to be lysosomes [72]. Pharmacological or genetic 
inhibition of lysosomal function impairs membrane resealing in fibroblasts, and knockout 
of synaptotagmin-VII (a dysferlin homolog present on lysosomes) impairs lysosomal 
exocytosis and inhibits membrane resealing in fibroblasts [71]. Several studies have 
also implicated endocytosis in membrane resealing. In NRK cells treated with SLO toxin 
(which forms transmembrane pores) enzyme release due to lysosomal-exocytosis 
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facilitates rapid endocytosis of toxin pores and this coupling may be required for 
membrane resealing at least in this model of toxin-induced wounding [78]. In giant 
crayfish neurons or cockroach neurons, endocytic vesicles directly contribute to 
membrane resealing following axotomy by forming a vesicular plug at the membrane 
lesion [79]. In Aplysia neurons, axotomy induces microtubule based transport of 
vesicles toward the cut end of the axon, indicating that microtubule-based transport of 
vesicles may contribute to membrane repair [80]. Although there is no unifying 
mechanism of membrane resealing, and the cellular components involved appear to 
vary, these studies highlight the critical role for vesicle-vesicle and vesicle-membrane 
interactions during membrane resealing, and provide clues for the potential role for 
dysferlin in membrane resealing in muscle. 
 
The cytoskeleton is a critical regulator of membrane resealing in non-muscle cells: The 
cytoskeleton is a critical regulator of membrane remodeling and membrane transport 
processes across a wide variety of cell types [81]. In sea urchin embryos, delivery of 
vesicles to membrane lesions is mediated by microtubules, and disruption of 
microtubules or kinesin-motors (the major outwardly directed motor along microtubules) 
inhibits membrane resealing [77]. In fibroblasts, while microtubules are not required for 
resealing initial wounds, disruption of microtubules impairs membrane resealing 
following multiple wounds [82]. This can be explained, in part, by the fact that 
microtubules undergo dramatic re-orientation toward membrane wounds, and deliver 
newly synthesized Golgi-derived vesicles to replenish those used during resealing the 
initial wound [82]. The sub-membrane actin cytoskeleton is critical for membrane 
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resealing in sea urchin embryos, as disruption of actin filaments or inhibition of myosin 
motors inhibits damage-induced exocytosis and membrane resealing [77]. A role for 
actin-dependent non-muscle myosin motors in membrane repair has also been 
confirmed in fibroblasts [83] and potentially muscle cells [67]. Furthermore, In drosophila 
embryos and Xenopus Oocytes, membrane lesions are repaired via the formation of an 
actin and myosin-II "contractile ring" which, through direct interactions with cadherin, 
generates a pulling force to "close" lesions in the plasma membrane [84, 85]. 
Subsequent studies have also determined that proteins that regulate actin dynamics, 
such as Rho-kinase, are activated in response to wounding [86]. F-actin accumulates at 
membrane lesions in primary human myotubes [87], but whether an analogous 
mechanism of F-actin contractile ring formation contributes to membrane resealing in 
muscle cells remains to be explored.  
 
Membrane repair in muscle and the role of dysferlin: 
Membrane damage and repair in muscle: Plasma membrane disruption is a common 
occurrence in dystrophic muscle, and normal muscle following injurious contractions or 
prolonged endurance exercise, and often can be marked pathologically by staining 
muscle sections for infused vital dyes, or by staining for intracellular accumulation of 
normally non-permant extracellular soluble proteins [13]. Although dysferlin-deficient 
muscle does not appear to be more susceptible to membrane damage than normal 
muscle, several lines of evidence indicate that membrane resealing may be impaired in 
dysferlin deficient muscle [18]. Dysferlin-null muscle fibers show increased uptake of 
membrane impermeable FM1-43 dye following laser-induced wounding, indicating that 
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dysferlin-null muscle cells do not repair the membrane as efficiently as normal muscle 
(Fig 1-3B and C). Furthermore, dysferlin is enriched at sites of cellular wounding in adult 
skeletal muscle fibers, indicating that recruitment of dysferlin at membrane lesions is 
critical for membrane resealing [18]. Electron micrographs of dysferlin-null muscle show 
dramatic accumulation of vesicles under the plasma membrane near putative 
membrane lesions, which supports the model that vesicle-vesicle or vesicle-PM fusion 
of dysferlin-containing vesicles may be critical for resealing in muscle cells [18]. 
Recently, mutations within several additional proteins have been shown to impair 
membrane resealing in muscle cells, and their potential interaction with dysferlin, as well 
as their contribution to membrane resealing is currently being addressed [52, 53]. MG53 
is a tri-partate motif protein that is highly expressed in muscle, and MG53 knockout 
mice display a dystrophic phenotype characterized by high CK, centrally nucleated 
fibers, muscle weakness and inflammatory infiltrate [51]. MG53 accumulates at 
membrane lesions via non-muscle myosin-II (NMII), and inhibition of NMII with 
blebbistatin decreases MG53 accumulation and impairs membrane resealing [67], 
consistent with a role for the actin cytoskeleton in membrane resealing in muscle. MG53 
accumulation may represent an initial activating event in membrane repair, as MG53 
accumulates at membrane lesions prior to dysferlin, and dysferlin accumulation at 
lesions may be dependent on MG53 expression [52]. Strikingly, MG53 accumulation is 
not calcium-dependent, instead MG53 undergoes oxidation-dependent oligomerization 
at membrane lesions following exposure to the oxidative extracellular environment [51]. 
Caveolins are critical components of caveolae, which regulate endocytosis across a 
wide variety of cell types [88]. Mutations in a muscle specific caveolin, Caveolin-3, result 
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in a LGMD phenotype in humans [8], and over-expression of P140L mutant caveolin-3 
in mice causes muscle disease, as a result of impaired membrane resealing. 
Furthermore, resealing deficits in this model appear to be due to altered interactions 
between MG53 and dysferlin [52]. Caveolin positive vesicles form following membrane 
wounding, which may contribute to membrane resealing, but whether these vesicles 
contain critical repair proteins has not been explored [89]. Annexins accumulate at 
membrane lesions in both non-muscle (annexin 1, 5), and muscle cells (annexin A6, 
A2a, A1a) [53, 90], and recruitment of annexin A2 and A1 is dependent on dysferlin in 
zebrafish muscle [90]. These studies indicate that the interaction between dysferlin and 
proteins involved in membrane trafficking may underlie the role of dysferlin in 
membrane repair, and this is supported by a growing body of biochemical evidence that 
dysferlin may mediate critical membrane fusion events during membrane repair in 
skeletal muscle. 
 
Dysferlin as a critical regulator of membrane fusion during membrane resealing in adult 
skeletal muscle: The C2A domain of dysferlin is capable of binding lipids in a calcium 
dependent manner, consistent with a role for dysferlin in the calcium activated fusion 
events that are required for membrane resealing [42, 91]. The additional C2 domains 
(C2B-F) bind lipids independently of calicum, which indicates that these domains may 
be constitutively bound to lipids, however the relevance of the lipid binding capacity of 
these domains to membrane resealing is not clear [42]. In addition to lipid binding, the 
C2 domains of dysferlin are thought to play a critical role in regulating protein-protein 
interactions and these interactions may be critical for resealing. For example, the 
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interaction between dysferlin and MG53 is mediated by the C2A domain in-vitro [92]. 
Recently, structure-function analyses have demonstrated that a mini-dysferlin 
containing only the C2A, C2F and transmembrane domain is sufficient to restore 
membrane repair capacity in dysferlin-deficient myotubes, but whether mini-dysferlin is 
sufficient to restore muscle function in dysferlin-deficient mouse models is not known 
[29]. Therefore, recruitment of dysferlin to membrane lesions could facilitate membrane 
repair by enhancing vesicle-vesicle and vesicle-membrane fusion specifically at 
membrane lesions.  
 
The mechanism by which dysferlin-containing compartments contribute to membrane 
resealing is not clear: Although the resealing defect associated with dysferlin-deficiency 
is well described, there is still a fundamental lack of understanding as to how dysferlin-
containing membranes contribute to membrane resealing in adult skeletal muscle. 
Figure 1-4 outlines the currently hypothesized model for dysferlin-mediated membrane 
resealing, which indicates that sarcolemmal wounding leads to localized calcium influx, 
subsequent vesicle-vesicle and vesicle-sarcolemma fusion of dysferlin-containing 
vesicles to form a dysferlin-rich "patch" over the membrane lesion [18] (Fig 1-4). 
However, there is little direct evidence in support of this model. Dysferlin localizes to 
intracellular vesicles in differentiating myotubes [93], and adult dysferlin-null muscle 
shows accumulation of sub-sarcolemmal vesicles of unknown composition [18], but a 
study that examined dysferlin localization using electron microscopy of normal skeletal 
muscle immunolabeled for dysferlin concluded that dysferlin is restricted to the plasma 
membrane [16]. Furthermore, the biochemical composition of dysferlin-containing 
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vesicles has not been defined [18]. Furthermore, a recent study examining the 
contribution of dysferlin to membrane repair in zebrafish muscle concluded that dysferlin 
expression may be restricted to the plasma membrane [90]. There have also been very 
few studies attempting to examine the behavior of dysferlin-containing membranes 
following membrane wounding. Therefore, a more thorough examination of dysferlin-
containing compartments and development of novel reagents to examine the behavior 
of those compartments following wounding is critical to understanding the function of 
dysferlin-containing membranes in membrane resealing. There is some evidence to 
suggest that dysferlin-containing membranes interact with the cytoskeleton in 
differentiated myotubes [94], however, the relevance of these interactions to dysferlin-
mediated membrane resealing is not clear.  
 
Rationale and Approach: 
Membrane repair is critical for muscle function but the exact contribution of dysferlin-
containing membranes to resealing is not clear: Mutations in several proteins involved in 
membrane repair result in muscle disease [18, 51], and enhancing membrane repair 
capacity may be a viable therapeutic approach for muscle diseases [95]. However, a 
more thorough understanding of membrane resealing in normal muscle is critical in 
order to design novel therapeutics aimed at enhancing membrane repair. Dysferlin-
containing membranes are thought to contribute to membrane repair, but the exact 
function of dysferlin-containing membranes in membrane repair in muscle is not clear. 
Furthermore, whether the cytoskeleton is required for the function of dysferlin-containing 
membranes during membrane repair in muscle is not clear. Therefore, the overall goal 
18 
 
of the work in this thesis was to examine the dynamic behavior of dysferlin-containing 
membranes and examine the role of the cytoskeleton in dysferlin-mediated membrane 
repair in skeletal muscle. In this thesis, I tested the overall hypothesis that dynamic 
interactions between the cytoskeleton and dysferlin-containing membranes are 
critical for membrane resealing in skeletal muscle. Live-cell imaging based 
approaches were developed to investigate the behavior of dysferlin-containing 
membranes in differentiated myotubes expressing dysferlin-eGFP, or adult skeletal 
muscle fibers isolated from a muscle specific transgenic reporter mouse expressing 
dysferlin-pHGFP. Genetic or pharmacological disruption of the cytoskeleton or motor 
proteins was used to examine the role of the cytoskeleton in dysferlin-mediated 
membrane repair.  
 
Specific Aim 1: Examine the behavior of dysferlin-containing membranes following 
wounding and determine the role of the cytoskeleton in dysferlin-mediated membrane 
repair in differentiating myotubes.  
 
The purpose of the experiments outlined in Aim 1 was to examine the behavior of 
dysferlin-containing vesicles following wounding and the role of the cytoskeleton in 
regulating that behavior in differentiated myotubes. Although dysferlin-containing 
vesicles have been implied as critical mediators of membrane repair in muscle, there is 
actually limited evidence that this is the case. L6 myotubes expressing fluorophore 
labeled dysferlin molecules were subjected to live-cell imaging to examine the behavior 
of dysferlin-containing compartments prior to and following membrane wounding with or 
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without pharmacological or genetic disruption of the cytoskeleton/motor proteins. Our 
data indicates that dysferlin-containing vesicles undergo vesicle-vesicle fusion following 
membrane disruption which generates large dysferlin-containing vesicles that may act 
as a vesicular plug to reseal membrane lesions. Pharmacological disruption of 
microtubules or genetic inhibition of kinesin motors impairs large vesicle formation likely 
through direct inhibition of vesicle function following wounding. This data supports the 
overall model that microtubule-dependent vesicle-vesicle fusion of dysferlin-containing 
vesicles is critical for membrane resealing in differentiated myotubes. 
 
Specific Aim 2: Examine the behavior of dysferlin-containing membranes following 
wounding and determine the role of the cytoskeleton in dysferlin-mediated membrane 
repair in adult skeletal muscle.  
 
The purpose of the experiments outlined in Aim 2 was to examine the contribution of 
dysferlin-containing membranes to membrane repair in adult skeletal muscle. A novel 
muscle-specific transgenic mouse expressing dysferlin-pHluorin GFP was generated 
and used to examine the behavior of dysf-pHGFP prior to and following laser-induced 
wounding using confocal microscopy. The data indicate that dysferlin is restricted to the 
sarcolemma and t-tubules, with minimal dysferlin within vesicles at rest. Following 
wounding, adjacent sarcolemma-derived dysferlin is rapidly pulled into stable dysferlin-
rich structures surrounding the lesion. Interestingly, membrane damage also induces 
the formation of endocytic dysferlin containing vesicles, which may contribute to 
membrane repair by plugging wounds in the plasma membrane. Disruption of the actin 
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cytoskeleton impairs accumulation of sarcolemma derived dysferlin  as well as 
membrane resealing in adult skeletal muscle fibers with no effect on endocytosis. These 
findings support the overall model that actin-dependent recruitment of sarcolemma-
derived dysferlin contributes to membrane resealing by creating an "active-zone" of high 
lipid binding activity to facilitate interaction with dysferlin-containing or non-dysferlin 



































Figure 1-1. Loss of dysferlin results in muscular dystrophy independently of any effects 
on the DGC or membrane stability. The protein names in red boxes are components or 
interact directly with proteins in the dystrophin-glycoprotein complex (DGC). The DGC 
acts as a structural link between the actin-cortex (via dystrophin), through the plasma 
membrane (via dystroglycan) and the basal lamina (through laminin). Mutations in any 
component of the DGC are thought to destabilize the plasma membrane and result in 
susceptibility to contraction-induced sarcolemma wounding. Dysferlin is enriched in 
membrane fractions from muscle, but is not an integral component of the DGC. Loss of 
dysferlin does not affect DGC components, and does not alter membrane stability, 
which highlights an independent function for dysferlin in skeletal muscle cells. (Figure 




















Figure 1-2. A) Phylogenic analysis of and structure of ferlin proteins. Ferlins have a 
highly conserved structure highlighted by multiple tandem containing C2 domains (with 
the exception of Fer-1, which contains 1), ferlin and dysf-domains, and an extreme C-
terminal transmembrane domain. Ferlin proteins regulate a wide variety of membrane 
fusion events across several species and cell types, indicating that dysferlin may 
regulate membrane fusion in muscle. B) Orientation of dysferlin within the plasma 
membrane and/or intracellular vesicles. The long cytoplasmic N-terminal domain 
contains the C2 domains. The short c-terminal domain localizes to the lumen of 





Figure 1-3. Impaired membrane resealing in dysferlin-deficient muscular dystrophy. A) 
Simple schematic of membrane resealing. Contraction is thought to induce tears in the 
plasma membrane, particularly when genetic mutations in DGC components render the 
sarcolemma unstable. Lesions result in the leakage of intracellular molecules (Creatine 
Kinase, CK), and the uptake of extracellular ions/molecules (calcium and impermeable 
dyes), and subsequently cell death unless the cell repairs the lesion. Resealing is 
thought to require recruitment of intracellular vesicles to lesions in non-muscle cells, but 
the mechanism by which muscle fibers reseal the sarcolemma is largely unknown. B) 
Membrane repair is assayed in-vitro by incubating adult skeletal muscle fibers in 
membrane impermeable fluorescent FM1-43 dye and measuring the uptake of dye 
following laser-induced injury. C) Dysferlin-deficient muscle fibers take up more FM1-43 
dye than wild-type fibers following laser induced injury (quantification in D), indicating 
that membrane repair is defective in dysferlin-deficient muscle (representative data  


















Figure 1-4. Hypothesized model for dysferlin-mediated membrane repair in skeletal 
muscle. A) Dysferlin-containing vesicles are present under the sarcolemma of resting 
skeletal muscle fibers. Physical disruption of the sarcolemma results in a localized influx 
of extracellular calcium, which triggers dysferlin-dependent vesicle-vesicle (B) and 
vesicle-sarcolemma (C) fusion of dysferlin-containing vesicles. Fusion of dysferlin-
containing vesicles with the sarcolemma results in formation of a dysferlin-rich "patch" 
structure at the lesion, which restores the physical barrier between the cytosol and 
extracellular space (D). Therefore, dysferlin-deficiency is hypothesized to impair 
membrane resealing by impairing damage-induced vesicle fusion, but damage-induced 
fusion of dysferlin-containing vesicles and the dysferlin-containing compartments critical 












Membrane damage induced vesicle-vesicle fusion of dysferlin-containing vesicles 
in muscle cells requires microtubules and kinesin. 
 
ABSTRACT 
Mutations in the dysferlin gene resulting in dysferlin-deficiency lead to Limb-girdle 
Muscular Dystrophy 2B and Myoshi Myopathy in humans. Dysferlin has been proposed 
as a critical regulator of vesicle mediated membrane resealing in muscle fibers, and 
localizes to muscle fiber wounds following sarcolemma damage. Studies in fibroblasts 
and urchin eggs suggest that trafficking and fusion of intracellular vesicles with the 
plasma membrane during resealing requires the intracellular cytoskeleton. However, the 
contribution of dysferlin-containing vesicles to resealing in muscle and the role of the 
cytoskeleton in regulating dysferlin-containing vesicle biology is unclear. Here, live-cell 
imaging was used to examine the behavior of dysferlin-containing vesicles following 
cellular wounding in muscle cells and examine the role of microtubules and kinesin in 
dysferlin-containing vesicle behavior following wounding. Our data indicate that 
dysferlin-containing vesicles move along microtubules via the kinesin motor KIF5B in 
muscle cells. Membrane wounding induces dysferlin-containing vesicle-vesicle fusion 
and the formation of extremely large cytoplasmic vesicles, and this response depends 
on both microtubules and functional KIF5B. In non-muscle cell types, lysosomes are 
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critical mediators of membrane resealing, and our data indicate that dysferlin-containing 
vesicles are capable of fusing with lysosomes following wounding which may contribute 
to formation of large wound sealing vesicles in muscle cells. Overall, our data provide 
mechanistic evidence that microtubule-based transport of dysferlin-containing vesicles 
may be critical for resealing, and highlight a critical role for dysferlin-containing vesicle-
vesicle and vesicle-organelle fusion in response to wounding in muscle cells. 
 
INTRODUCTION 
Membrane damage is a frequent occurrence in mechanically active tissues, such as 
skeletal and cardiac muscle, and successful repair of the cell membrane following 
disruption is critical to muscle function [12, 18, 32]. Mutations within a critical 
membrane-repair protein, dysferlin, leads to two mild but progressive forms of muscular 
dystrophy termed Limb-Girdle Muscular Dystrophy 2B (LGMD2B) and Myoshi Myopathy 
(MM)[23, 97]. Dysferlin is a single-pass transmembrane protein containing multiple 
cytoplasmic C2 domains, and is a member of the evolutionarily conserved ferlin family 
of proteins. Ferlin proteins play a critical role in membrane fusion across multiple 
species and cell types [38]. Dysferlin appears to have evolved in higher order 
vertebrates and is relatively muscle specific, with the highest expression in mature 
skeletal and cardiac muscle [17]. Dysferlin is expressed predominantly at or near the 
plasma membrane in normal adult skeletal muscle, and is markedly mislocalized into 
the cytoplasm in skeletal muscle from patients with Duchenne muscular dystrophy, as 
well as Limb-girdle muscular dystrophies caused by genetic mutations in genes other 
than dysferlin [20]. Furthermore, combined deficiency of dystrophin and dysferlin 
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worsens disease progression in mice, highlighting the critical role for dysferlin both in 
normal, and diseased skeletal muscle [34]. While the functions of dysferlin in muscle 
that are important for its causal role in muscular dystrophy and the mechanisms of 
those functions are still unclear, dysferlin has been suggested to play a role in a wide 
variety of processes related to membrane fusion, including t-tubule biogenesis and 
maintenance [46], cell-cell fusion [47], cell adhesion [45], and muscle growth [98]. 
Perhaps the most intensively studied role for dysferlin is in the process of membrane 
resealing. Membrane resealing is a conserved process by which cells are able to 
survive mechanical disruption of the plasma membrane [64, 76, 77, 83]. Dysferlin-null 
skeletal and cardiac muscle show enhanced uptake of membrane impermeable dye 
following laser-induced wounding suggesting dysferlin may play a role in membrane 
resealing [18, 61]. Dysferlin is enriched at sites of cellular damage, and these "patches" 
are devoid of plasma membrane proteins, indicating dysferlin may have been delivered 
from an intracellular membrane source [18, 61]. Electron micrographs of dysferlin-
deficient muscle fibers show robust accumulation of vesicles under the sarcolemma, 
suggesting that in wild-type muscle, dysferlin may play a role in fusion of sub 
sarcolemma vesicles with the plasma membrane and that these vesicles may be critical 
to repairing the membrane following wounding [18]. Although these data are consistent 
with a role for dysferlin-containing vesicles in membrane resealing in skeletal muscle, 
exactly how dysferlin containing vesicles contribute to membrane resealing in muscle 
cells is not clear. 
Current knowledge of membrane resealing is largely derived from studies in the 
sea urchin egg and fibroblast model systems, which demonstrated that fusion of 
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intracellular vesicles with the plasma membrane is critical for resealing [76, 77, 83, 99]. 
Dysferlin localizes to the plasma membrane and intracellular vesicles in developing 
myotubes, and interacts with numerous proteins involved in membrane transport, 
including caveolin-3 [93], annexin-4 [97], annexin-6 [90], enlargeosomal marker AHNAK 
[100], and tubulin [94], but the exact contribution of dysferlin-containing vesicles to 
resealing following wounding remains elusive, as few studies have examined the 
behavior of dysferlin-containing vesicles in live cells following cellular wounding. 
Therefore, the behavior of dysferlin-containing vesicles in live muscle cells prior to and 
following wounding, the role of kinesin and microtubules in dysferlin-vesicle biology was 
examined.  
Live-cell imaging of L6 myotubes expressing fluorescently-tagged dysferlin 
molecules was used to study the real time dynamic behavior dysferlin-containing 
vesicles prior to, and following mechanical membrane disruption. These data 
demonstrate that dysferlin-containing vesicles interact with microtubules via plus-end 
directed kinesin heavy chain motor, KIF5B. In response to membrane damage, 
dysferlin-containing vesicles undergo rapid vesicle-vesicle and vesicle-organelle fusion 
with lysosomes to form extremely large cytoplasmic vesicles, in a manner that is 
dependent on both microtubules and functional KIF5B. These data support the overall 
hypothesis that the interaction of dysferlin-containing vesicles with microtubules is 
critical for dysferlin-vesicle function following cellular wounding, and implicate lysosomal 
membranes as potential partners for dysferlin-containing vesicle fusion events following 





Mouse dysferlin isoform-1 (Gen Bank: NM_021469) was obtained as a kind gift from the 
Jain Foundation. A C-terminal fragment of dysferlin was isolated using a BSTBI-NOT1 
fragment, and sub cloned into a TOPO PCR 2.1 shuttle vector. The remaining N-
terminal portion of dysferlin was excised using a KPNI-BSTBI digestion and inserted 
into the dysferlin C-terminus PCR2.1 vector. An eGFP fragment was generated using 
custom primers which generated a 5’SACII-eGFP-NOTI 3’ fragment in PCR 2.1. The 
GFP fragment was then excised using a SACII-NOTI digest, and inserted into the 
dysferlin containing vector at the C-terminus. The entire dysferlin-GFP construct was 
then excised using a KPNI-NOTI digestion and inserted into a PCDNA 3.1+ vector for 
mammalian expression. Dysferlin-mCherry was generated using PCR amplification of 
mCherry with custom primers to generate a 5’SACII-mCherry-NOTI fragment. This 
fragment was then inserted into the aforementioned Dysferlin-eGFP construct using a 
SACII-NOTI digest. All dysferlin constructs were sequenced by the University of 
Michigan Sequencing Core. Motorless kinesins (containing the C-terminal stalk-tail 
region) are generally used as dominant negative inhibitors of kinesin function [101]. 
Constructs encoding GFP or mCherry labeled full-length rat KIF5 and dominant 
negative KIF5B (amino acids 568-964) were obtained as a kind gift from Dr. Kristen 
Verhey. Previous work has shown that KIF5B and KIF5C interact, and that KIF5B can 
compensate for the loss of KIF5C [102], as such these constructs were used 
interchangeably throughout this manuscript. Thanks to Dr. Kristen Verhey for the 
fluorophore labeled kinesin and LGP120 constructs used in this study. Rat anti-α tubulin 
polyclonal antibody (AB6161) was obtained from ABCAM. Rabbit polyclonal antibody to 
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Protein disulfide isomerase (PDI) was obtained from Sigma. Mouse monoclonal 
antibody to GM130 was obtained from BD transduction labs. Nocodazole (Methyl N-(5-
thenoyl-2-benzimidazolyl)carbamate) was obtained from Sigma Aldrich. Blebbistatin 
(1,2,3,3a-Tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4H-pyrrolo[2,3-b]quinolin-4-one) 
was obtained from Toronto Research Chemicals Inc. Alexa 488-conjugated phalloidin 
was obtained from Life Technologies. Anti Lamp-1 antibody was obtained from ABCAM 
(ab24170). Lipofectamine™ 2000 reagent was used in all transfection experiments. 
 
Cell Culture and Transfection: L6 myocytes were grown on 100mm dishes under 
standard conditions at 37C + 5% CO2 in the presence of DMEM+10% FBS +1% P/S. 
Cells were sub-cultured using PBS wash followed by treatment with 0.25% trypsin-
EDTA and plated on either 100mm dishes for continued sub-culturing or 35mm glass 
bottom dishes (MatTek) for live-cell imaging, or glass coverslips contained in 6-well 
dishes for immunofluorescence. L6 myocytes were transfected or co-transfected with 
cDNA(s) of interest using Lipofectamine 2000, according to the manufacturer’s protocol. 
Following transfection, cells were switched to DMEM+2% Horse Serum and allowed to 
differentiate for 4-8 d until cells formed elongated myotubes. 
 
Immunofluorescence and Image Analysis: Differentiated L6 myotubes were fixed for 
15min in 3% paraformaldehyde, and permeabilized for 1h in block solution containing 
5% Bovine Serum Albumin and 0.5% triton X-100. Following blocking, cells were 
incubated in block solution containing the appropriate titer of antibody at room 
temperature for 1.5h. Following incubation in primary antibody, cells were washed and 
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incubated in block solution containing the appropriate secondary antibody for 1h. DAPI 
was used to stain nuclei in all immunofluorescence experiments. Images were obtained 
on the Deltavision ® system using standard filter sets or a Leica SP8 confocal 
microscope with a 63x objective where indicated. For deltavision imaging, optical 
sections were generated at a thickness of 0.2 um for each channel and the resulting raw 
data was used to create projection images in SoftWoRx 1.3.0. Adobe Photoshop CS2 
and Adobe Illustrator were used to compile images. 
 
Live-cell Imaging and Quantification of Dysferlin-containing vesicle Transport: Dysferlin-
eGFP expressing L6 myotubes were switched from differentiation media to PBS + Ca2+ 
prior to imaging. Imaging was carried out on an Olympus BX-71 Deltavision® 
microscope, equipped with a climate control chamber to maintain 37ºC and 5% CO2. All 
imaging data was obtained on the Deltavision® live-cell system with an Olympus 60x, 
1.4 numerical aperture objective, equipped with a PhotometricsCoolSnap HQ 
monochromatic camera. SoftWoRx Explorer 1.3 ® imaging software was used in all 
experiments to analyze raw time-lapse data. SoftWoRx 3.5.0 ® software was used to 
deconvolve time-lapse data when indicated, and was carried out using enhanced ratio 
with medium noise filtering unless otherwise noted. Quicktime movies or individual 
image files were generated from raw time-lapse data. Dysferlin-containing vesicle 
movement and nocodazole treatment: For analysis of dysferlin-containing vesicle 
movement, dysferlin-eGFP expressing L6 myotubes were imaged at 250ms exposure 
for 2m prior to nocodazole treatment. To determine the effect of microtubule disruption 
on dysferlin-containing vesicle transport, cells were incubated in 750mM nocodazole for 
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30m and subjected to a second round of live-cell imaging for 2min. Raw time-lapse 
images were then analyzed for dysferlin-containing vesicle movements >2um in length 
using Softworx ® Particle Tracking software by an observer blind to treatment group. 
Each individual motile vesicle was tracked through time and the total distance traveled 
was determined by manually assigning XY-coordinates to each motile vesicle at time-
point. Each vesicle moving greater than 2um was counted as a movement, and the total 
number of movements was compared for each cell, prior to, and after treatment with 
nocodazole. Significance was determined using a student’s T-test. Velocities of 
individual dysferlin containing vesicles (24 movements from 10 cells) were calculated by 
tracking individual motile vesicles and calculating the change in xy distance over time. 
This data should be taken as a close approximation, as our methodology does not 
account for displacement of vesicles within the z-plane.  
 
Live-cell imaging of co-transfected L6 myotubes: To study multiple fluorescently tagged 
molecules, in single cells, experiments were designed to alternate imaging between 
each channel at 250msec exposure for 2min. The raw data for each channel was 
analyzed independently and in combination for vesicle motility and colabeling of 
dysferlin vesicles with molecules of interest. Movie files and images of individual and 
merged time-lapse data were generated for further analysis. Raw data and quicktime 
files were analyzed for colocalization, as well as the dynamic movement of both labels 




Live-cell Membrane Damage Assay: To study the behavior of dysferlin-containing 
vesicles following membrane disruption, L6 myotubes expressing dysferlin-eGFP were 
subjected to live-cell imaging. Each cell was imaged in the GFP channel at 250msec 
exposure for 2min prior to membrane damage. Following initial imaging, each cell was 
re-visited and cells were wounded using a glass pulled micropipette and imaged for 4-
5min following wounding. To damage myotubes, an MX140-R manual micromanipulator 
was mounted to the stage of an Olympus BX-71 Deltavision® microscope and equipped 
with a finely pulled glass pipette. Wounding was confirmed visually by the absence of 
fluorescence in the affected area, as well as hypercontracture of the myotube. Using 
these criteria over 90 percent of the cells that were assayed were characterized as 
wounded. Cells that did not hypercontract were re-wounded or discarded. Due to 
movement artifact following membrane wounding, the z-axis was adjusted when 
necessary to highlight structures of interest. To quantify the vesicle formation response 
of dysferlin-eGFP expressing myotubes to membrane disruption, raw time lapse (.dv) 
files were analyzed using SoftWorx Explorer 1.3 for the formation of large dysferlin-
vesicles following wounding. Any cell that formed dysferlin-containing vesicles with a 
visible lumen that was not present prior to wounding was characterized as a 
“responder,” and any cell that did not form vesicles was excluded from the analysis. For 
each responding cell, the total number of large (>2um) damage-induced dysferlin-
containing vesicles was quantified at a single time point after vesicle formation had 
subsided. For nocodazole experiments, cells were incubated with DMSO or DMSO+ 
750nM nocodazole for ≥ 30min prior to wounding, imaged in the GFP channel at 250 
msec exposure for 2min prior to wounding, and 4-5 min following wounding. For 
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dominant negative kinesin experiments, imaging alternated between GFP and dsRed 
channels at 250 msec exposure for 2min to confirm expression of both constructs. 
Following initial imaging, each cell was wounded and imaged in the GFP channel alone 
at 250msec exposure for 4-5min. To determine the effect of nocodazole or dominant 
negative KIF5 on large vesicle formation, the average number of large vesicles (>2µm) 
was quantified and compared to the respective control (DMSO or wt-KIF5, respectively). 
The data is presented as a bar graph in figure 5B and 6C, and represents data collected 
from multiple independent experiments. Data is presented as mean +/- SE and 




Dysferlin-eGFP localizes to distinct cytoplasmic vesicles in differentiated L6 
myotubes.  Fluorescently-tagged dysferlin fusion constructs were generated to study 
the localization and behavior of dysferlin-containing vesicles in cultured skeletal muscle 
cells. Deconvolution imaging of L6 myotubes transiently expressing dysferlin-eGFP 
revealed that dysferlin-containing membranes and vesicles were present in linearly 
arranged clusters throughout the length of the myotube (Fig 2-1 A). The exact 
composition of dysferlin-containing vesicles, and whether these vesicles are derived 
from any known membrane compartments remains to be determined. Antibody labeling 
of endoplasmic reticulum marker, PDI (Fig 2-1B), as well as Golgi marker GM130 ( Fig 
2-1 C), in dysferlin-eGFP expressing myotubes was used to examine the relationship 
between dysferlin-containing vesicles and the secretory pathway in skeletal muscle 
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cells. Dysferlin-eGFP showed minimal overlap with either GM130, or PDI, indicating that 
dysferlin-containing vesicles are distinct from the secretory pathway. Dysferlin-eGFP 
and LGP120-mCherry localize to distinct vesicular structures when coexpressed in L6 
myotubes, indicating that dysferlin-eGFP does not localize to lysosomes in skeletal 
muscle cells (Fig 2-1D).   
 
Dysferlin-containing vesicles move along microtubules via KIF5B motors in 
differentiated L6 myotubes. Live-cell imaging of fluorophore labeled dysferlin 
expressing L6 myotubes was used to explore the dynamic behavior of dysferlin-
containing vesicles, and the relationship between dysferlin-containing vesicles and 
microtubules as well as kinesin motors in cultured L6 myotubes. The majority of 
dysferlin-containing vesicles, particularly those clustered within the cytoplasm or near 
the membrane, were non-motile over the course of imaging (~2 min) except for 
occasional back-and-forth movements. However, a portion of dysferlin-containing 
vesicles moved in linear paths along the longitudinal axis of the myotube up to tens of 
microns in length at an approximate average rate of 0.63 +/- 0.045 µm/sec (Fig 2-2A). 
Due to the remarkable length and linearity of dysferlin-containing vesicle movements, 
we proposed that microtubules may serve as tracks for dysferlin-containing vesicle 
transport in skeletal muscle. Microtubules were antibody labeled in fixed dysferlin-eGFP 
expressing L6 myotubes in order to explore the relationship between dysferlin-
containing vesicles and microtubules in skeletal muscle. Microtubule structures 
arranged in a dense longitudinally oriented lattice that extended throughout the entire 
myotube, and a portion of dysferlin-containing vesicles were associated with 
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microtubules (Fig 2-2B, see inset). To directly assess whether microtubules are required 
for dysferlin-containing vesicle transport in L6 myotubes, movement of dysferlin-vesicles 
was analyzed for long-range (>2µm) vesicle movements in dysferlin-eGFP expressing 
L6 myotubes prior to, and following treatment with nocodazole. As shown in figure 2-2C, 
treatment with 750nM nocodazole clearly disrupted the microtubule lattice and 
significantly reduced vesicle movements >2µm in differentiated L6 myotubes (Fig 2-2D). 
We examined whether dysferlin-containing vesicles labeled with ubiquitously expressed 
kinesin motor KIF5B by imaging L6 myotubes co-expressing dysferlin-mCherry and 
GFP-KIF5B and analyzed the dynamic movement of each label relative to the other in 
live skeletal muscle myotubes. Motile and non-motile cytoplasmic dysferlin-containing 
vesicles are labeled by GFP-KIF5B in L6 myotubes (Fig 2-2E), but not neuron specific 
isoform KIF5C (Fig 2-7), indicating that dysferlin-containing vesicles contain KIF5B 
motors in L6 myotubes.  
 
Membrane disruption induces formation of extremely large dysferlin-containing 
vesicles in L6 myotubes. There have been few studies attempting to directly examine 
damage-induced fusion of dysferlin-containing vesicles following wounding in living 
skeletal muscle cells. Therefore, to characterize the response of dysferlin-containing 
vesicles to membrane disruption in skeletal muscle cells, we used in-vitro mechanical 
wounding of dysferlin-eGFP expressing L6 myotubes in conjunction with live-cell 
imaging to track the dynamic responses of dysferlin-containing vesicles. Mechanical 
wounding has been used previously to study the behavior of other repair proteins in 
muscle cells [51], but the response of dysferlin-containing vesicles to mechanical 
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wounding has not been fully characterized. Prior to wounding, dysferlin-containing 
vesicles were distributed throughout the cytoplasm of the myotube (Fig 2-3A, left). 
Cellular damage was elicited using a glass pulled micropipette guided to a precise 
location on the myotube, and allowed to puncture the membrane. Damage was 
indicated by: (1) loss of GFP-fluorescence in the affected area, and (2) noticeable tactile 
response, including membrane tearing and subsequent retraction of the myotube. 
Immediately following disruption, dysferlin-containing vesicles combine to form 
extremely large cytoplasmic vesicles adjacent to the lesion, and throughout the 
cytoplasm (Fig 2-3A, white arrows, right panel). The resulting vesicles varied in size 
from 1µm to greater than 10µm. All vesicles forming following wounding had an 
apparent lumen, which was not the case for dysferlin-containing vesicles prior to 
membrane disruption. The time-course of large-vesicle formation was rapid, beginning 
as rapidly as 1 sec post-wound and completely formed around 1 min post wound. 
Representative time-lapse images of large vesicle formation following wounding is 
presented in high magnification in figure 2-3B, where multiple small vesicles are 
incorporated into a large vesicle within a time-frame of 1 sec to form an incrementally 
larger vesicle (white arrows, right panel). In some instances, damage-induced vesicles 
collapsed into the adjacent membrane (Fig 2-3C), while the vast majority persist many 
minutes following wounding (Fig 2-3D).  
 
Disruption of microtubules but not inhibition of actin-myosin interaction 
diminishes formation of large dysferlin-containing vesicles following membrane 
disruption in L6 myotubes. Our data suggests that dysferlin-containing vesicles 
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interact with microtubules and microtubule disruption inhibits vesicle movement. 
Therefore, the requirement of microtubules for fusion of dysferlin-containing vesicles 
following wounding in L6 myotubes was examined. Dysferlin-eGFP expressing L6 
myotubes were pre-treated with either DMSO or DMSO + 750nM nocodazole for ≥ 30m 
and subjected to live-cell imaging prior to, and following membrane disruption. Time-
lapse data was analyzed for fusion of dysferlin-containing vesicles and the resulting 
formation of large-vesicles with a visible lumen. Dysferlin-eGFP expressing L6 
myotubes were not affected by pre-treatment with DMSO (Fig 2-4A, top-left), and 
mechanical wounding induced formation of extremely large vesicles in DMSO treated 
cells (Fig 2-4A, top-right, supplementary movie 6). Treatment with nocodazole did not 
affect dysferlin-containing vesicle localization within the cell prior to wounding (Fig 2-4A, 
middle-left panel), but the formation of large dysferlin-containing vesicles following 
wounding was significantly reduced (Fig 2-4A middle-right panel, quantified in Fig 2-4B, 
supplementary movie 7). To determine whether the inhibitory effect of nocodazole 
treatment on formation of large dysferlin-containing vesicles was specific for microtubule 
disruption or due to indirect disruption of actin-based transport, dysferlin-eGFP 
expressing L6 cells were acutely treated with a potent and specific non-muscle myosin-
II inhibitor, blebbistatin, and assayed for fusion following mechanical wounding. 
Treatment with 25uM blebbistatin did not markedly alter dysferlin-containing vesicle 
localization and did not affect the formation of large dysferlin-containing vesicles 




Functional KIF5B is required for formation of large dysferlin-containing vesicles 
following membrane disruption. Our data indicates that KIF5B labels dysferlin-
containing vesicles and may be a critical motor protein for movement of dysferlin-
containing vesicles along microtubules in skeletal muscle cells. Therefore, over-
expression of a dominant negative KIF5B construct was used to examine the role of 
KIF5B in the formation of large dysferlin-containing vesicles following mechanical 
wounding in L6 myotubes. The dominant negative KIF5B encodes a “headless” 
truncation mutant of KIF5B, which contains half of the stalk domain and cargo-binding 
domain, but lacks a functional motor domain. Deconvolution imaging of fixed L6 
myotubes expressing dysferlin-eGFP and either wild-type mCherry-labeled KIF5C 
(mCherry-wtKIF5) or mCherry-labeled dominant negative mutant of KIF5B (mCherry-
dnKIF5), revealed that localization of dysferlin-containing vesicles was not markedly 
affected by expression of either construct (Fig 2-5A). Genomic deletion of KIF5B has 
been reported to disrupt organization of the Golgi complex, actin cytoskeleton, 
lysosomes in KIF5B-null myoblasts [102, 103]. Therefore, we examined whether 
expression of dnKIF5 affected the Golgi complex, actin cytoskeleton, and lysosomes in 
differentiated L6 myotubes. Over-expression of dnKIF5 did not disrupt the actin-
cytoskeleton or the Golgi complex in L6 myotubes (Fig 2-9A, B). Lysosomal 
organization was not affected by expression of dnKIF5, as most lamp-1 positive 
structures were dispersed throughout the cytoplasm of wtKIF5 and dnKIF5 expressing 
cells (Fig 2-9C). To examine the role of KIF5B in the formation of large dysferlin-
vesicles, myotubes co-expressing either dysferlin-eGFP and mCherry-wtKIF5 (Fig 2-5B, 
top-left panel) or dysferlin-eGFP and mCherry-dnKIF5 (Fig 2-5B, bottom-left panel) 
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were subjected to mechanical wounding and assayed for the formation of large 
dysferlin-containing vesicles. Expression of mCherry-wtKIF5 did not affect the behavior 
of dysferlin-containing vesicles following wounding as membrane disruption induced the 
formation of large dysferlin vesicles adjacent to the lesion site (Fig 2-5B, top-right). 
Expression of mCherry-dnKIF5 significantly reduced the formation of large dysferlin-
containing vesicles following wounding, indicating that functional KIF5B is required for 
formation of large dysferlin-containing vesicles following wounding in skeletal muscle 
cells (Fig 2-5B, bottom-right panel, quantified in Fig 2-5C).  
 
Dysferlin-containing vesicles undergo heterotypic fusion with lysosomes 
following mechanical wounding in differentiated L6 myotubes. Lysosomes are 
thought to undergo exocytosis in response to membrane wounding, and have been 
implicated in membrane resealing in non-muscle cell systems [72]. Interestingly, 
lysosomal marker LAMP-2 is mislocalized in dysferlin-null myoblasts indicating a 
possible defect in lysosomal transport [98], but whether lysosomal compartments 
interact with dysferlin vesicles in muscle cells is not known. To address this, L6 
myotubes co-expressing dysferlin-eGFP and LGP120-mCherry (LGP120-mCh) were 
subjected to live-cell imaging prior to, and following mechanical wounding and the 
extent of co-labeling was analyzed. Prior to membrane wounding, dysferlin-eGFP and 
LGP120-mCh label independent vesicle populations with minimal overlap (Fig 2-6A, top 
panels). Large co-labeled structures form following mechanical wounding, indicating 
that dysferlin-containing vesicles are capable of fusion with lysosomal compartments in 
L6 myotubes following cellular wounding (Fig 2-6A, bottom panels). High magnification 
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time-lapse images of heterotypic dysferlin/lysosome vesicle formation are shown in 
figure 2-6B.  
 
DISCUSSION 
Dysferlin is a critical component of the membrane repair machinery in both skeletal and 
cardiac muscle [18, 61], and loss of this protein leads to muscular dystrophy [18, 37, 
104]. Dysferlin-containing vesicles are thought to play a critical role in muscle resealing, 
but there have been very few studies attempting to directly examine the behavior of 
dysferlin-containing vesicles in live muscle cells in the context of cellular wounding. 
Studies from non-muscle model systems suggest that microtubule-based transport of 
intracellular vesicles is critical for resealing [77, 82], but the role of microtubules and 
kinesin motors in dysferlin-mediated membrane repair in muscle remains unexplored. 
Therefore, the aim of this study was to examine the behavior of dysferlin-containing 
vesicles under normal conditions and following cellular wounding in muscle cells, and 
test the hypothesis that microtubules and kinesin are required for dysferlin-containing 
vesicle function in muscle cells. Due to the dynamic nature of vesicle transport/fusion 
and membrane resealing, we used a live-cell imaging approach to study dysferlin-
containing vesicles in unperturbed and mechanically wounded myotubes. This approach 
allowed for the resolution of individual vesicle movements and direct visualization of 
vesicle fusion events following cellular wounding in live-muscle cells. Our data show 
that dysferlin-containing vesicles are transported along microtubules via kinesin heavy 
chain isoform KIF5B, and undergo rapid microtubule- and KIF5B-dependent fusion to 
form extremely large vesicles following cellular wounding in skeletal muscle cells. 
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Furthermore, we identify lysosomal compartments as potential interacting partners of 
dysferlin-containing vesicles following cellular wounding in skeletal muscle cells. 
 
Dysferlin-containing vesicles move along microtubules via KIF5B in skeletal 
muscle cells. Antibody labeling of microtubules in fixed dysferlin-eGFP expressing L6 
myotubes revealed that dysferlin-containing vesicles are arranged along longitudinally 
oriented microtubule structures. Live-cell imaging of dysferlin-eGFP expressing L6 
myotubes showed that the majority of dysferlin-containing membranes are arranged in 
non-motile vesicle clusters, with a small fraction of dysferlin-containing vesicles 
undergoing microtubule-dependent long range movement. Kinesin heavy chain has 
been implicated in damage-induced exocytosis of vesicles in other model systems [77, 
83], and a study that screened for dysferlin interacting proteins using mass 
spectrometry identified ubiquitous kinesin motor KIF5B [105]. Consistent with a role for 
KIF5B on dysferlin-containing vesicles, live-cell imaging of L6 myotubes expressing 
dysferlin-mCh and eGFP-KIF5B revealed that dysferlin-containing vesicles are labeled 
by KIF5B, and co-labeled vesicles are capable of long-range movements. Furthermore, 
the measured velocity of motile dysferlin-containing vesicles is in the range of velocities 
reported for mitochondria in neurons [106], and kinesin motors in COS cells [107]. 
Interestingly, most KIF5B labeled dysferlin-containing vesicles did not show long-range 
processive movement and are limited to local movements in resting L6 myotubes.  
These findings are consistent with reports describing processive and non-processive 
movements of kinesin bound cargoes [108, 109]. Possible explanations for the non-
processive behavior of a subpopulation of kinesin containing dysferlin vesicles are that 
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KIF5B may be bound to dysferlin-containing vesicles without sufficiently activating 
kinesin motor activity or without actively engaging microtubules [108] or perhaps the 
clustering of vesicles limits their motility or anchors them to another sub cellular 
structure.   
 
Dysferlin-containing vesicles undergo fusion to form large cytoplasmic vesicles 
following cellular wounding in L6 myotubes. L6 myotubes expressing dysferlin-
eGFP were subjected to mechanical wounding using a finely pulled glass pipette and 
analyzed for fusion of dysferlin-containing vesicles following wounding. Mechanical 
wounding reproducibly led to contracture and ultimately retraction of the myotube away 
from the wound site. This model of injury, in contrast to single point laser injury, is more 
analogous to the process of contraction induced injury that occurs in muscle in vivo [14]. 
In dystrophin-deficient dystrophic muscle, injurious lengthening contractions result in 
complete fiber tearing and the formation of contraction clots at the site of tearing [14]. 
Interestingly, rather than accumulate specifically at membrane lesions in the L6 injury 
model, dysferlin-containing vesicles undergo rapid vesicle-vesicle fusion to form a 
population of extremely large dysferlin-containing vesicles throughout the cytoplasm of 
the myotube. In some cases the vesicles collapse on the membrane, but the majority of 
large vesicles remain in the cytoplasm and are stable for minutes following injury. This 
finding was somewhat surprising as our expectation was that dysferlin-containing 
vesicles would accumulate specifically at membrane lesions and fuse with the plasma 
membrane. The vesicle formation response was reminiscent of the "vesicular plug" 
model of membrane resealing as has been previously documented in the urchin egg 
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and crayfish medial giant axon, whereby endocytic and exocytic vesicles undergo fusion 
adjacent to membrane lesions and plug the lesion with minimal fusion with the plasma 
membrane [57, 75]. Therefore, we propose that formation of large dysferlin vesicles 
may act as a vesicular plug which is, in itself, acting as a cellular “contraction clot” 
capable of plugging large wounds in the plasma membrane of skeletal muscle cells. 
Additionally, it is interesting to speculate that cytoplasmic dysferlin-containing vesicles 
could play a different yet unappreciated role in response to wounding in muscle cells 
such as sequestering cytoplasmic components or damaged organelles that would 
otherwise harm neighboring cells. In fact, this idea is supported by recent evidence that 
the complement system is activated in dysferlin-null muscle, which contributes directly 
to disease progression, and may result from excess leakage of cellular contents 
following wounding [110]. 
 
Disruption of the functional linkage between dysferlin-containing vesicles and 
microtubules inhibits formation of large dysferlin-containing vesicles following 
wounding in L6 myotubes. Due to the presence of KIF5B on dysferlin-containing 
vesicles and the requirement of microtubules for dysferlin-containing vesicle movement, 
we hypothesized that disruption of microtubules and/or kinesin motors would inhibit 
formation of large dysferlin-containing vesicles following wounding in L6 myotubes. We 
addressed this hypothesis by examining the effect of pharmacological disruption of 
microtubules or dominant negative inhibition of KIF5 motors on the formation of large 
dysferlin-vesicles following wounding in L6 myotubes. Both microtubule disruption and 
expression of dominant negative KIF5B significantly reduced the formation of large 
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dysferlin-containing vesicles following wounding in differentiated L6 myotubes. These 
findings taken together with the fact that KIF5B is present on dysferlin-containing 
vesicles indicates that the functional linkage between KIF5B on dysferlin-containing 
vesicles and the microtubule lattice is critical for formation of large dysferlin vesicles 
following cellular wounding in L6 myotubes. There are several ways in which disrupting 
the link between microtubules and dysferlin-containing vesicles could inhibit large 
vesicle formation in muscle cells. It is possible that dysferlin-containing vesicles are 
transported throughout the cytoplasm via KIF5B prior to wounding and inhibition of 
KIF5B inhibits proper trafficking of dysferlin. However, the finding that dominant 
negative KIF5B does not markedly alter dysferlin localization indicates that transport of 
dysferlin-containing vesicles off of the Golgi apparatus is intact, and cytoplasmic 
targeting of dysferlin-containing vesicles does not require KIF5B. One possible 
explanation for the dominant negative effect of KIF5B on vesicle formation is that KIF5B 
is required for movement of dysferlin-containing vesicles along microtubules following 
wounding, and this movement facilitates coalescence of adjacent dysferlin-containing 
vesicles. In this scenario, inhibition of KIF5B could impair large vesicle formation by 
disrupting proper movement of dysferlin-containing vesicles along microtubules 
following wounding. Unfortunately, analysis of motility following wounding in our assay 
was limited by the fact that wounding caused dramatic contracture of the myotube, 
resulting in movement of most cellular components. Regardless, our data indicate that 
the interaction between functional KIF5B motors on dysferlin-containing vesicles and 




Dysferlin-containing vesicles fuse with lysosomal compartments following 
wounding in L6 myotubes. The exact composition of dysferlin-containing vesicles, and 
membrane compartments involved in membrane repair in muscle have not been fully 
examined. Lysosomes have been implicated in membrane resealing across a variety of 
non-muscle cell types [72], but whether lysosomes are involved in dysferlin-mediated 
membrane resealing in skeletal muscle cells is not known. Lysosomal marker Lamp-2 
accumulates around the nucleus of dysferlin-null myoblasts [48], indicating that loss of 
dysferlin may adversely affect lysosomal function. Furthermore, dysferlin is required for 
Fas-L induced lipid raft clustering in endothelial cells, which is thought to be dependent 
on lysosomal fusion [111]. Therefore, we sought to directly examine whether dysferlin-
containing vesicles interact with lysosomal compartments following wounding in skeletal 
muscle cells. Live cell imaging of L6 cells co-expressing dysferlin-eGFP and LGP120-
mCh shows that dysferlin-eGFP and LGP120-mCh label independent populations of 
vesicles prior to wounding. Following wounding, dysferlin-containing vesicles undergo 
fusion with LGP120-mCh labeled compartments to form large vesicles in L6 myotubes. 
A previous study reported that lysosomal dispersion is impaired in cells isolated from 
KIF5B knockout mice, indicating that KIF5B may be required for motility of lysosomes 
[102]. Our data indicates that lysosomal organization is not dramatically altered by 
dnKIF5B expression in differentiated L6 myotubes. This finding, taken together with the 
fact that KIF5B is present on dysferlin-containing vesicles prior to wounding indicates 
that the dominant negative effect on large-vesicle formation is likely through direct 
impairment of dysferlin-containing vesicle function rather than an indirect effect on 
lysosomal function. These data support the novel assertion dysferlin-containing vesicles 
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may interact to form large-vesicles following wounding which may contribute to 
membrane repair in L6 myotubes. Interestingly, knockout of synaptotagmin-VII, a 
dysferlin homolog necessary for lysosomal fusion, displays an inflammatory muscle 
myopathy [71], but whether loss of lysosomal function impairs resealing in muscle cells 
is not known. Furthermore, additional studies are needed to examine the exact 
contribution of lysosomal compartments to resealing in muscle and whether lysosomal 
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Figure 2-1. Dysferlin-eGFP localizes to a population of distinct vesicles in 
differentiated L6 myotubes. A) Dysferlin-containing vesicles are arranged in linear 
arrays throughout the cytoplasm of L6 myotubes. High magnification of (A) shows that 
dysferlin-containing vesicles are isolated (arrowhead, right panel), and also accumulate 
in regularly distributed vesicle clusters (arrow, right panel). Antibody labeling of fixed L6 
myotubes shows that cytoplasmic dysferlin-containing vesicles do not colocalize with 
endogenous ER marker PDI (B), or Golgi marker GM130 (C). D) Dysferlin-eGFP and 
lysosomal marker mCherry-LGP120 localize to distinct vesicle populations in 












Figure 2-2. Dysferlin-containing vesicles move along microtubules via KIF5B 
motors in differentiated L6 myotubes. A) Live-cell imaging of Dysferlin-eGFP 
expressing L6 myotubes shows that dysferlin-containing vesicles undergo long-range 
movements along the longitudinal axis of L6 myotubes (Supplementary movie 1). B) 
Antibody labeling of α -tubulin in dysferlin-eGFP expressing L6 myotubes reveals that 
dysferlin-containing vesicles colocalize with microtubules in L6 myotubes; DAPI=blue. 
C) Antibody labeling of α-tubulin in differentiated L6 myotubes shows that microtubules 
form a dense, longitudinally oriented lattice in L6 myotubes (C, left-panel) and are 
disrupted following treatment with microtubule depolymerizing agent, nocodazole (C, 
right-panel)D) Microtubule disruption inhibits long-range movement of dysferlin-
containing vesicles in skeletal muscle myotubes. Dysferlin-eGFP expressing myotubes 
were imaged 2min prior to, and following treatment with nocodazole, and vesicle 
movements greater than 2um were quantified for each condition (n=13, p< 0.001). E) 
Dysferlin-containing vesicles label with KIF5B motors in skeletal muscle myotubes. Data 





Figure 2-3. Membrane damage induces fusion of dysferlin-containing vesicles 
leading to the formation of extremely large vesicles in L6 myotubes. A) Membrane 
disruption induces the formation of large dysferlin-containing vesicles in L6 myotubes. 
L6 myotubes expressing dysferlin-eGFP were subjected to live-cell imaging prior to and 
after membrane disruption with a glass micropipette. Prior to damage, dysferlin-
containing vesicles appear regularly distributed throughout the cytoplasm (left-panel). 
Following damage (arrowhead), dysferlin-containing vesicles (shown in left panel) 
undergo rapid vesicle-vesicle fusion to form extremely large vesicles adjacent to 
membrane lesion (white arrows), and throughout the cytoplasm (Supplementary movie 
3). B) Large damage-induced dysferlin-containing vesicles result from fusion of smaller 
dysferlin-containing vesicles in L6 myotubes. Analysis of high magnification, 
consecutive live-cell images shows small vesicles (arrowheads) undergo fusion with a 
large vesicle to form an incrementally larger vesicle (Supplementary movie 4). C) 
Example of large dysferlin-containing vesicle collapsing with the plasma membrane 
following membrane disruption (Supplementary movie 5). D) The majority of damage-
induced dysferlin-containing vesicles persist for many minutes following membrane 




Figure 2-4. Disruption of microtubules reduces the formation of large dysferlin-
containing vesicles following membrane wounding in L6 myotubes. A) Effect of 
pharmacological inhibition of microtubules on large vesicle formation following wounding 
in L6 myotubes. Prior to damage, dysferlin-containing vesicles show typical 
arrangement in linear arrays throughout the cytoplasm of differentiated L6 muscle cells 
(left-panels). In DMSO treated control cells dysferlin-containing vesicles fuse to form 
large vesicles following membrane disruption (arrowheads, top-right panel). Disruption 
of microtubules by pre-treatment with nocodazole markedly reduces the formation of 
large dysferlin-containing vesicles following wounding (middle-panels). B) Quantification 
of large dysferlin-containing vesicle formation. The left panel is a representative image 
showing multiple vesicles (arrowheads) greater than 2um in size (white bar). The total 
number of large vesicles per cell was quantified for DMSO and Nocodazole treatment 
(bar graph). Treatment with nocodazole significantly reduced the number of large 
vesicles formed following wounding compared to DMSO control (n=15 cells for DMSO; 
n=9 cells for Nocodazole; p<0.05). See supplementary movie 6 (DMSO), and 7 




Figure 2-5. Expression of dnKIF5 inhibits formation of large dysferlin-containing 
vesicles following membrane wounding in L6 myotubes. A) Expression of dominant 
negative KIF5 does not dramatically alter dysferlin-containing vesicle localization in L6 
myotubes. Representative deconvolved images of fixed L6 myotubes co-expressing 
dysferlin-eGFP (green) and either mCherry labeled wtKIF5 (left, red) or mCherry labeled 
dnKIF5 (right, red); DAPI=blue. B) Dominant negative KIF5 inhibits formation of large 
dysferlin-containing vesicles following membrane disruption in L6 myotubes. L6 
myotubes expressing dysferlin-eGFP and mCherry-wtKIF5 control or mCherry-dnKIF5 
constructs were analyzed prior to (left panels) and following mechanical wounding 
(right-panels) using live cell imaging. Formation of damage-induced large dysferlin 
vesicles is diminished in dnKIF5 expressing (bottom-right) but not wtKIF5 expressing 
myotubes (arrows, top-right). C) Quantification of large dysferlin-containing vesicle 
formation. The left panel is a representative image showing multiple vesicles (arrows) 
greater than 2um in size (red bar). The total number of large vesicles per cell was 
quantified for myotubes expressing dysferlin-eGFP with mCherry-wtKIF5 or mCherry-
dnKIF5 (bar graph). Expression of dnKIF5 significantly reduces the formation of large 
dysferlin-containing vesicles following mechanical disruption in L6 myotubes. wtKIF5 
n=13 cells, dnKIF5 n=10 cells; p<0.05. Supplementary movie 8 (wtKIF5) and 9 




Figure 2-6. Dysferlin-eGFP interacts with lysosomal membranes following 
mechanical wounding in differentiated L6 cells. A) Dysferlin-eGFP and LGP120-
mCh occupy distinct compartments in unwounded L6 myotubes (top panels), and form 
large colabeled cytosolic vesicles following mechanical wounding (bottom panels). B) 
High magnification time-lapse imaging of dysferlin-eGFP (top panels, starting from left) 
and LGP120-mCh (bottom panels, starting from left) from cell shown in panel (A). Small 
interspersed dysferlin-containing vesicles and LGP120 containing membranes undergo 
heterotypic fusion to form a large vesicle adjacent to the membrane lesion (time 









Figure 2-7. Dysferlin-containing vesicles do not 
label with KIF5C in differentiated L6 myotubes. 
L6 myotubes co-expressing dysferlin-eGFP 
(top panel) and mCherry-Kif5C (middle panel) 
were subjected to live cell imaging to examine 
the relationship between dysferlin-containing 
vesicles and mcherry-KIF5C motors in muscle 
cells. Cytoplasmic dysferlin-containing vesicles 
do not label with KIF5C (insets), indicating that 
dysferlin-containing vesicles do not contain 
KIF5C motors in differentiated L6 myotubes. 
































Figure 2-8. Pharmacological inhibition of actomyosin interaction does not affect 
formation of large dysferlin-containing vesicles following wounding in differentiated L6 
myotubes. Dysferlin-eGFP expressing L6 myotubes were treated with DMSO (A) or 
DMSO +/- 25uM Blebbistatin (B), subjected to mechanical wounding and analyzed for 
large vesicle formation. Treatment with blebbistatin did not alter the localization of 
dysferlin-containing structures within the cell (B, left) and large dysferlin-containing 
















Figure 2-9. Effect of dominant negative KIF5 on the organization of the actin-
cytoskeleton, Golgi-complex, and lysosomes in differentiated L6 myotubes. L6 
myotubes expressing either wtKIF5 (left panels) or dnKIF5 (right panels) were fixed and 
labeled for actin (A), Golgi marker GM130 (B) or lysosomal marker lamp-1 (C), and 
examined by confocal microscopy. There were no obvious differences in the 
organization of the actin cytoskeleton (A), or Golgi Apparatus (B). Lamp-1 positive 
structures were dispersed throughout the cytoplasm of wtKIF5 and dnKIF5 expressing 
myotubes (C). For clarity, wtKIF5 and dnKIF5 expression is shown in the insets in panel 











Rapid actin cytoskeleton dependent recruitment of plasma membrane-derived 




Deficits in membrane repair may contribute to disease progression in dysferlin-deficient 
muscular dystrophy.  Dysferlin, a type-II transmembrane phospholipid binding protein, is 
hypothesized to regulate fusion of repair vesicles with the sarcolemma to facilitate 
membrane repair, but the dysferlin-containing compartments involved in membrane 
repair and the mechanism by which these compartments contribute to resealing is 
unclear.  A dysferlin-pHluorin (dysf-pHGFP) muscle-specific transgenic mouse was 
developed to examine the dynamic behavior and sub-cellular localization of dysferlin 
during membrane repair in adult skeletal muscle fibers.  Live-cell confocal microscopy of 
uninjured adult dysf-pHGFP muscle fibers revealed that dysferlin is highly enriched in 
the sarcolemma and t-tubules.  Laser-wounding induced rapid recruitment of ~30μm of 
local dysferlin-containing sarcolemma, leading to formation of stable dysferlin 
accumulations surrounding lesions, and endocytosis of dysferlin and formation of large 
cytoplasmic vesicles from distal regions of the fiber.  Disruption of the actin-cytoskeleton 
decreased recruitment of sarcolemma-derived dysferlin to lesions in dysf-pHGFP fibers 
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without affecting endocytosis and impaired membrane resealing in wild-type fibers 
similar to dysferlin-deficiency (2-fold increase in FM1-43 uptake).  Our data support a 
new mechanism whereby recruitment of sarcolemma-derived dysferlin creates an 
“active-zone” of high lipid-binding activity at wounds to interact with repair vesicles and 
facilitate membrane resealing in skeletal muscle. 
 
INTRODUCTION 
Dysferlin is ~220kDa type-II transmembrane protein that is highly expressed in adult 
skeletal and cardiac muscle [17].  Loss of dysferlin expression leads to a delayed but 
progressive muscle disease, presenting either in the limb-girdle (LGMD2B) or in distal 
muscles (Myoshi Myopathy) [23].  Although the pathology of dysferlin-deficiency is well 
described, the exact role of dysferlin within muscle cells is largely unknown.  Dysferlin 
has been implicated in various cellular processes such as muscle cell-cell fusion during 
regeneration [33], muscle growth [48], and cell adhesion [44, 45].  Perhaps the most 
intensively studied cellular role for dysferlin is as a critical component for membrane 
resealing in skeletal muscle and cardiac muscle cells [18, 61].  Membrane resealing is a 
critical and evolutionarily conserved mechanism by which cells are able to withstand 
transient disruptions of the plasma membrane [62, 64].  Although the exact mechanism 
by which cells reseal the plasma membrane may vary depending on cell type, most 
cells utilize recruitment of intracellular vesicles capable of fusing with each other, and or 
the plasma membrane to repair the membrane lesion [70].  
Muscle cells are thought to undergo frequent membrane disruption as a result of 
mechanical activity, particularly when mutations in other important cell adhesion 
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proteins causing human muscular dystrophies render the sarcolemma susceptible to 
mechanical injury, and in such cases, resealing may be critical for cell survival [112].  
The proposed role of dysferlin in membrane resealing is based on the finding that 
dysferlin-deficient muscle fibers take up membrane impermeable FM1-43 dye to a 
greater extent than wild-type fibers following laser-induced sarcolemma wounding [18].  
Furthermore, dysferlin accumulates at membrane lesions in resealed skeletal muscle 
fibers, along with other proteins proposed to be involved in resealing including MG53 
and annexin-VI [51, 53], and recruitment of additional repair proteins may be impaired in 
dysferlin-deficient muscle [90].  Dysferlin-containing vesicles are hypothesized to play a 
role in resealing due to the dramatic accumulation of vesicles under the sarcolemma of 
dysferlin-deficient muscle [18], but the composition of dysferlin-containing vesicles and 
the involvement of dysferlin-containing vesicles in resealing has not been definitively 
shown in adult skeletal muscle fibers.  Mechanistic analysis of resealing in non-muscle 
cell types supports a role for the cytoskeleton and exocytosis of intracellular vesicles in 
membrane resealing [62, 64, 76], but whether the cytoskeleton plays a role in dysferlin-
mediated resealing in adult muscle fibers is not known.  Therefore, the goal of our study 
was to examine the behavior of dysferlin-containing membranes during membrane 
repair, and examine the role of the cytoskeleton in dysferlin recruitment and membrane 
resealing in adult skeletal muscle.  
 We generated a novel transgenic mouse (termed dysf-pHGFP TG) expressing a 
dysferlin-pHluorin GFP fusion protein (dysf-pHGFP) specifically in muscle cells, and 
used this model to study the dynamic behavior and of dysferlin-containing membranes 
in response to laser-induced membrane disruption in live adult skeletal muscle cells in-
60 
 
vitro.  Our data indicate that dysferlin is enriched in the sarcolemma and transverse 
tubules (t-tubules) in resting adult skeletal muscle fibers, with no detectable dysf-
pHGFP in vesicles in resting fibers.  During membrane repair, sarcolemma-derived 
dysferlin is rapidly pulled into the lesion where it forms a stable dysferlin-rich structure at 
the sarcolemma which may be critical for membrane resealing in adult skeletal muscle 
fibers.  Additionally, wounding induces endocytosis and formation of large dysferlin-
containing vesicles which may contribute to act as vesicular plugs to repair membrane 
lesions.  Pharmacological disruption of the actin-cytoskeleton blocks the recruitment of 
sarcolemma-derived dysferlin at lesions and impairs membrane resealing without 
disrupting dysferlin endocytosis and formation of dysferlin-containing intracellular 
vesicles.  Therefore, our data supports a new model that the dysferlin-containing 
membrane required for membrane resealing is actually derived from the sarcolemma, 
and that rapid, actin-cytoskeleton dependent recruitment of dysferlin-containing 
membrane into stable enrichments at the wound site represents a critical step in the 
membrane resealing process. 
 
METHODS 
Generation of dysf-pHGFP transgenic mice: Murine dysferlin isoform 1 with a C-terminal 
pHGFP [113] tag was cloned into PBSII SK+ vector downstream of the muscle creatine 
kinase promoter [114], and used to generate a transgenic mouse on an inbred C57/Bl6 
background by the University of Michigan Transgenic Core (described in detail below).  
A C-terminal fragment of murine dysferlin isoform-1 was sub-cloned from a pDNOR 
vector, resulting in a BSTBI-NotI fragment within PCR 2.1 shuttle vector.  The remaining 
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N-terminal dysferlin sequence was inserted using a KPNI-BSTBI digest resulting in full 
length dysferlin within PCR2.1. A fragment containing pHGFP [113] flanked by a 5' SacII 
and 3' NotI was generated using PCR and inserted into the Dysferlin-PCR2.1 plasmid 
using a SacII-NotI digest.  The resulting dysf-pHGFP fragment was isolated and 
inserted into PCDNA 3.1 for mammalian expression.  A poly-A sequence was inserted 
on the 3' end of the coding sequence by cloning a pA fragment containing a 5' EAGI site 
and 3' SPEI, KPNI, and NOTI sites.  The pA sequence was inserted into dysf-pHGFP 
PCDNA 3.1 using a NotI digest.  The full length MCK promoter [114] was inserted 5' to 
the dysf-pHGFP-pA PCDNA 3.1 construct with a KPNI-NOTI digest.  The entire cDNA 
was excised and linearized using a NotI-SpeI digest.  Purified DNA was microinjected 
into fertilized eggs obtained by mating C57BL/6J female mice with C57BL/6J male mice. 
Pronuclear microinjection was performed as described[115]. 
 
Western blotting: Skeletal and cardiac muscle KCl-washed microsomes were isolated 
from adult wild-type and dysf-pHGFP TG mice and analyzed by SDS-PAGE and 
Western Blotting as described [116].  Membranes were blotted for anti-dysferlin (NCL-
Hamlet, Novacastra/Leica, Buffalo Grove, IL, USA) or anti-GFP (AB13970, Abcam, 
Cambridge, MA, USA) followed by secondary HRP-conjugated antibodies (Jackson 
Immunoresearch, West Grove, PA, USA) and chemiluminescence detection.  
 
Muscle fiber isolation, imaging, and staining: Single muscle fibers were isolated from 
adult mouse flexor digitorum brevis muscles as described [117].  Briefly, FDB muscles 
were isolated from anaesthetized adult wild-type or dysf-pHGFP TG mice and incubated 
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in MEM + 0.2% collagenase for 4 hr at 37ºC with gentle shaking.  Following incubation, 
muscles were switched to MEM+10% FBS, residual connective tissue was removed 
using forceps, and the muscle was triturated using progressively smaller diameter glass 
pipettes to liberate single muscle fibers.  Isolated muscle fibers were allowed to adhere 
for 20 minutes on glass-bottom cover dishes pre-plated with 10% matrigel in MEM + 
10% FBS.  Live fibers were imaged on a Leica SP8 Confocal microscope at 37ºC using 
63x oil objective at 1.5x zoom at 512x512 resolution using an argon laser at excitation: 
488nm and detection at 498-525nm (GFP) or 580-620nm (FM1-43).  For live-cell 
experiments, cells were imaged in a physiological saline solution (PSS) pH 7.4 
containing (in mM) 15 Hepes, 145 NaCl, 5.6 KCl, 2.2 CaCl, 0.5 MgCl, 5.6 Dextrose.  To 
quench the pHGFP oriented toward the extracellular buffer, citrate buffer was used in 
place of HEPES with pH adjusted to 5.5 using concentrated HCl.  To alkalinize 
intracellular vesicles, NaCl was reduced 95 mM and 50mM NH4Cl was added to 
physiological saline solution [118].   Quantification of fluorescence intensity prior to, and 
following acid wash (or NH4Cl treatment) was carried out by quantifying mean 
fluorescence intensity within the entire visible region of the muscle fiber and using raw 
intensity data to generate percent change values.  For staining experiments, cells were 
fixed for 15min in 3% paraformaldahyde, and permeabilized for 1hr in block solution 
containing 5% BSA and 0.1% triton-x.  Cells were stained with Romeo anti-dysferlin 
(Abcam) at 1:100 dilution for 1.5hr followed by labeling with 1:200 goat-anti rabbit Cy3 
(Jackson Immunoresearch).For staining experiments, cy3 channel was imaged using 
white light laser at 550nm excitation and detection from 560-595, and all images were 




Membrane injury experiments: Membrane injury protocols were performed similar to 
previous studies measuring laser-wounding induced FM1-43 uptake in adult skeletal 
muscle fibers [18].  Cells were imaged for 3 frames prior to wounding, and every 1.5s 
for 2-5 minutes after the onset of membrane damage.  Membrane damage was elicited 
by exposing a 2 x 2 μm ROI at the lateral membrane to a multiphoton laser at a fixed 
intensity, tuned to 890nm for ~2 sec.  Recruitment of dysferlin at membrane lesions was 
analyzed by quantifying dF/Fo (which is (Ft-Fo)/Fo, where Ft equals mean fluorescence 
at time=t, and Fo equals initial fluorescence) within a 10 x 5 μm ROI surrounding the 
lesion at 10s intervals following wounding.  Quantification of “total” cellular pHGFP 
fluorescence was carried out by quantifying dF/Fo within an ROI spanning the entire 
cell.  Quantification of FM1-43 dye uptake was carried out by quantifying mean dF/Fo 
following wounding within a 40x40 μm ROI.  For cytochalasin D experiments cells were 
pre-treated with either 0.1% DMSO or 50μm Cytochalasin D for 1.5 h and cytochalasin 
D was included in the imaging solution.  In experiments where high resolution images of 
wounded fibers are presented, high resolution images (1024x1024 resolution, line 
average 3) were taken following completion of the wounding protocol.  
 
FRAP experiments: To bleach specific populations of dysf-pHGFP within muscle fibers, 
a 30x5μm ROI at the plasma membrane, or 30x10μm ROI within the transverse tubules 
was bleached for 3 frames at 3 separate z-planes (+/-1μm) using an argon laser at 
488nm.  Successful photobleaching was confirmed visually, and lack of photobleach 
induced wounding was confirmed using DIC optics.  Images were taken prior to 
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bleaching, post-bleach, and for 2-5 minutes following a laser-induced wound delivered 
in the geographical center of the pre-bleached region. 
 
Statistics: All values are presented as Mean +/- SE.  Significance was determined 
based on a Student’s t-test, significance was set at p<0.05. 
 
RESULTS 
Generation of dysf-pHGFP TG reporter mice. We generated a cDNA encoding 
murine dysferlin with a C-terminal pHluorin GFP tag (dysf-pHGFP), and generated an 
MCK-driven muscle-specific transgenic mouse (dysf-pHGFP TG) expressing the dysf-
pHGFP transgene in striated muscle (Fig 3-1A).  Based on the topology of dysferlin as a 
type-II transmembrane protein, the dysf-pHGFP reporter molecule places a pH-sensitive 
GFP on the extracellular face of the plasma membrane and transverse tubules or the 
lumen of dysferlin-containing vesicles (Fig 3-1B).  GFP fluorescence from dysf-pHGFP 
is visible around the periphery of skeletal muscle fibers within transverse sections of 
dysf-pHGFP TG skeletal muscle (Fig 3-1C, right) but not wild-type muscle (Fig 3-1C, 
left).  The peripheral localization of dysf-pHGFP near or in the sarcolemma is similar to 
what has been previously reported for endogenous dysferlin using antibody labeling in 
adult skeletal muscle [18].  Western blotting for dysferlin with the NCL-hamlet antibody 
identified a prominent band (~240 kDa) in wild-type skeletal muscle microsomes and an 
upward shifted band corresponding to dysf-pHGFP specifically in transgenic skeletal 
(Fig 3-1D, top) and cardiac muscle microsomes (Fig 3-8, top).  Western blot using an 
anti-GFP antibody revealed a strong band at ~260 kDa corresponding to dysf-pHGFP 
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specifically in transgenic skeletal (Fig 3-1D, bottom) and cardiac microsomes (Fig 3-8, 
bottom).  Interestingly, we identified several lower molecular weight fragments of 
dysferlin expressed at lower levels detected by both anti-GFP and anti-dysferlin 
antibodies in transgenic microsomes, indicating the presence of C-terminal dysferlin 
cleavage products (Fig 3-9A).  However, a similar pattern of low molecular weight 
dysferlin antibody immunoreactive proteins was observed in wild-type skeletal muscle 
microsomes using the hamlet antibody at longer exposures, suggesting that both 
endogenous dysferlin and the dysferlin-pHGFP reporter undergo cleavage (Fig 3-9B, 
right panel).  Western blotting for dysferlin expression in wild-type and transgenic 
skeletal muscle microsomes at various dilutions (1:1 - 1:40) showed that the MCK 
dysferlin-pHGFP transgene results between 2.5 and 5-fold over-expression of dysferlin 
in skeletal muscles of dysf-pHGFP TG mice (Fig 3-1E).  Dysf-pHGFP TG skeletal 
muscle is morphologically normal based on comparative analysis of H & E staining of 
gastrocnemius muscles (Fig 3-1F), quantification of central fiber nucleation (Fig 3-1G), 
and measurments of plasma creatine kinase (not shown) in dysf-pHGFP-TG and age 
matched wild-type mice, indicating that dysf-pHGFP TG mice are free of muscle 
pathology into adulthood. 
 
Dysf-pHGFP is enriched in the plasma membrane and transverse tubules of adult 
skeletal muscle fibers and cardiac myocytes. The exact localization of dysferlin in 
adult muscle fibers and the composition of dysferlin-containing membrane 
compartments remain elusive.  GFP fluorescence in fixed adult skeletal muscle fibers 
isolated from dysf-pHGFP transgenic mice localized to the lateral sarcolemma and in a 
66 
 
striated internal membrane compartment, similar to immunofluorescence labeling of 
endogenous dysferlin in wild-type muscle fibers (Fig 3-2A and B).  In addition, dysf-
pHGFP fluorescence colocalizes extensively with immunofluorescence signal from 
“total” dysferlin with dysferlin antibodies in isolated adult transgenic skeletal muscle 
fibers (Fig 3-2C). Given that pHGFP fluorescence is quenched at low pH and 
fluorescence is high at high pH [119], our dysf-pHGFP reporter allows for the selective 
visualization of GFP signal based on surrounding pH (model shown in Fig 3-1B).  
Confocal imaging of live adult dysf-pHGFP TG skeletal muscle fibers (Fig 3-3A) and 
cardiac myocytes (Fig 3-8, left panels) at pH 7.4 revealed that dysf-pHGFP is visible at 
the lateral sarcolemma and a striated internal membrane compartment.  Changing the 
extracellular solution from physiological saline at pH 7.4 to physiological saline pH 5.5 
led to a significant reduction in fluorescence from live dysf-pHGFP TG skeletal (Fig 3-
3B, quantified in C) and cardiac myocytes (Fig 3-8B), demonstrating that dysferlin is 
highly enriched in the plasma membrane and t-tubules in adult muscle cells.  
Ammonium chloride (NH4Cl) is commonly used to alkalinize all cellular compartments 
and reveal pHluorin molecules within intracellular vesicles with an acidic luminal pH 
[119]. Surprisingly, treatment with 50mM ammonium chloride did not reveal additional 
internal dysf-pHGFP fluorescence in resting dysf-pHGFP TG skeletal muscle fibers (Fig 
3-3D, quantified in E), or cardiac myocytes (Fig 3-8C).  These data indicates that 
dysferlin is not primarily an intracellular vesicular protein but instead is primarily 




Adjacent sarcolemma-derived dysferlin is recruited to membrane lesions 
following wounding in adult skeletal muscle fibers. There have been very few 
studies examining the dynamic behavior of dysferlin in live adult muscle cells following 
wounding, and the dysferlin-containing membranes involved in membrane repair are not 
well defined.  To address this, adult skeletal muscle fibers isolated from dysf-pHGFP TG 
mice were imaged via confocal microscopy and the behavior of dysf-pHGFP was 
analyzed prior to and following laser-induced plasma membrane wounding.  Prior to 
membrane disruption, dysf-pHGFP localizes to the sarcolemma and t-tubules (Fig 3-4A, 
left).  Analysis of dysf-pHGFP localization during repair shows that the fluorescence 
signal rapidly increases at membrane lesions and results in a stable dysf-pHGFP-rich 
structure at the lesion (Fig 3-4A, B red arrows, quantified in 3-4C) consistent with either 
recruitment of sarcolemmal dysf-pHGFP or exposure of new pHGFP to the extracellular 
surface as a result of dysferlin-vesicle fusion with the plasma membrane.   Interestingly, 
pHGFP signal from the sarcolemma and t-tubule components in regions of the fiber 
considerably distant from the wound itself including the sarcolemma on the side 
opposite the wound, is rapidly quenched following wounding (Fig 3-4B white arrows, 
quantified in Fig 3-4D), indicating that dysferlin may also be rapidly endocytosed into 
acidic compartments following wounding.  
Given the rapid increase of dysf-pHGFP fluorescence at membrane lesions and 
our data indicating that dysferlin is restricted to the sarcolemma in resting fibers (Fig 3-
3), we tested the hypothesis that the dysferlin-containing membrane recruited to 
membrane lesions is derived from the adjacent sarcolemma in adult skeletal muscle 
fibers, rather than fusion of pre-existing dysferlin containing vesicles at the wound site.  
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To address this, the dysf-pHGFP fluorescence within a 30μm wide ROI at the plasma 
membrane was photobleached (pre-bleach shown in 3-4Ea, post-bleach in 3-4Eb) and 
movement of the adjacent GFP-positive dysferlin in the lateral sarcolemma were 
tracked following a 2μm wound delivered in the center of the pre-bleached ROI (Fig 3-
4Ec). Adjacent GFP-positive dysferlin containing sarcolemma is rapidly pulled toward 
the lesion and constricts the size of the pre-bleached regions without any evidence of 
new dysf-pHGFP appearing at the wound prior to lateral accumulation (Fig 3-4E).  
Representative line plots of GFP intensity spanning the sarcolemmal regions prior to 
wounding (Fig 3-4F), and post wound (Fig 3-4G) show that the photobleached region of 
plasma membrane is reduced following wounding due to recruitment of adjacent GFP-
positive sarcolemma. Conversely, dysf-pHGFP still accumulated at membrane lesions 
after laser-wounding in fibers subjected to protocols where the local t-tubule GFP 
fluorescence was photobleached prior to wounding (Fig 3-10).  This latter result 
indicates the t-tubule localized dysferlin does not appear to markedly contribute to the 
accumulation of dysferlin at membrane wounds. 
 
Membrane damage induces formation of endocytic dysferlin-containing vesicles 
in adult skeletal muscle fibers. Based on the finding that dysf-pHGFP fluorescence is 
reduced in regions of the sarcolemma and t-tubules distant from the wound, we 
proposed that dysferlin may also be endocytosed into acidic membrane compartments 
following wounding in adult muscle fibers.  To test this hypothesis, dysf-pHGFP TG 
muscle fibers were imaged at rest and for 1 min following wounding in physiological 
saline (PSS) at pH 7.4, and then switched to excess PSS +/- 50mM NH4Cl to reveal any 
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dysf-pHGFP residing in acidic compartments.  Switching wounded cells from PSS to 
PSS without NH4Cl had no effect on cellular fluorescence (Fig 3-5A) and did not reveal 
vesicle populations in high resolution images post-wounding (Fig 3-5B).  Switching 
wounded cells from PSS to PSS + 50mM NH4Cl led to a significant increase in cellular 
fluorescence back toward baseline (Fig 3-5C), which was associated with the presence 
of large dysferlin-containing vesicles throughout the cytoplasm of wounded fibers in high 
resolution images (Fig 3-5D).  Rapid wound-induced formation of large dysferlin 
containing vesicles is similar to what we have observed and recently reported in 
mechanically wounded dysferlin-GFP expressing myotubes [120].  
 
Pharmacological disruption of the actin-cytoskeleton impairs recruitment of 
sarcolemma-derived dysferlin without affecting formation of dysferlin-containing 
vesicles. The subcortical actin cytoskeleton plays an important role in membrane 
remodeling in many types of motile and mechanically active cells [81, 84]. Given the 
rapid formation and stability of dysferlin-rich structures at nascent membrane lesions in 
adult skeletal muscle fibers, we examined whether the subcortical actin cytoskeleton 
was required for recruitment of plasma membrane derived dysferlin in adult skeletal 
muscle fibers.  Dysf-pHGFP TG skeletal muscle fibers were pre-treated for 1.5 hr with 
either DMSO (Fig 3-6A) or DMSO + 50μM cytochalasin D (Fig 3-6B) assayed for 
recruitment of sarcolemma-derived dysferlin at laser-induced membrane lesions 
following wounding.  Treatment with cytochalasin D significantly reduced dysferlin 
recruitment following laser induced wounding compared to DMSO control (Fig 3-6B, 
quantified in Fig 3-6C), without markedly affecting damage-induced endocytosis of 
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dysferlin (Fig 3-6D).  Fibers wounded in the presence of either DMSO or DMSO + 
Cytochalasin D (shown in Fig 3-6A and B) were subsequently treated with physiological 
solution containing 50mM NH4Cl and analyzed at high resolution for the presence of 
dysferlin-containing vesicles.  Intracellular dysferlin-containing vesicles were visible in 
wounded DMSO treated (Fig 3-6A’) and wounded cytochalasin D treated fibers (Fig 3-
6B’) in the presence of NH4Cl.  These findings demonstrate that the recruitment of 
sarcolemma-derived dysferlin at membrane lesions requires the actin cytoskeleton, 
whereas endocytosis and formation of large dysferlin-containing vesicles following 
wounding occur independently of the actin cytoskeleton. 
 
Disruption of cytoskeletal actin impairs membrane resealing in adult skeletal muscle 
fibers. Consistent with previous studies examining the effect of dysferlin-deficiency on 
membrane resealing in adult skeletal muscle [18], dysferlin-deficient muscle fibers from 
the A/J mouse strain show increased uptake of FM1-43 following laser-induced 
wounding (Fig 3-7A, quantified in 7B). To determine whether cytoskeleton-mediated 
delivery of sarcolemmal dysferlin is required for efficient membrane repair in adult 
skeletal muscle fibers, wild-type muscle fibers were pre-treated for 1.5 hr with either 
DMSO or 50μM cytochalasin D (which was sufficient to impair dysf-pHGFP recruitment 
to membrane lesions in dysf-pHGFP skeletal muscle fibers) and assayed for uptake of 
FM1-43 dye following laser-induced wounding.  Treatment with cytochalasin D resulted 
in a 2-fold increase in FM1-43 uptake following wounding in adult skeletal muscle fibers 
(Fig 3-7C), comparable to that of dysferlin deficiency (Fig 3-7B) suggesting that 
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cytoskeleton-dependent recruitment of sarcolemma derived dysferlin at wounds is 
required for resealing in muscle fibers.  
 
DISCUSSION 
We generated a novel transgenic reporter mouse expressing dysf-pHGFP 
specifically in mature striated muscle cells, in order to examine the dynamic behavior of 
dysferlin following sarcolemma wounding and determine the role of the cytoskeleton in 
regulating dysferlin-mediated membrane repair in adult skeletal muscle in-vitro.  The 
dysf-pHGFP reporter molecule is expressed primarily as a full-length high molecular 
weight protein (~260 kDa) in transgenic skeletal muscle membranes detected by both 
anti-dysferlin and anti-GFP antibodies.  The isolation and identification of dysferlin 
containing membrane compartments has proven challenging with traditional 
biochemical techniques, and definitive evidence whether dysferlin is localized in the 
sarcolemma or in subsarcolemmal vesicles was still lacking [18]. Our dysf-pHGFP 
transgenic mouse is ideally suited to examine dysferlin localization in adult skeletal 
muscle cells given that it facilitates selective visualization of dysferlin localization and 
orientation in adult muscle fibers based on the ability to experimentally manipulate the 
surrounding pH.  The observed quenching dysf-pHGFP fluorescence in dysf-pHGFP TG 
fibers by lowering the extracellular pH indicates the C-terminal pHGFP is exposed to the 
extracellular environment at the sarcolemma and in t-tubules.  Furthermore, exposure of 
dysf-pHGFP TG fibers to NH4Cl, which is commonly used to reveal pHluorin reporter 
proteins sequestered in acidic intracellular vesicles [118, 119], does not increase 
cellular fluorescence.  Together this shows that dysferlin expression is largely restricted 
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to the sarcolemma and t-tubules in resting adult muscle fibers, and argues against the 
presence of an intracellular vesicle  pool containing dysferlin in resting adult skeletal 
muscle cells, which has been reported previously in developing myotubes [52, 93, 117, 
121]. This assertion is further supported by previous reports and data presented here 
showing that endogenous dysferlin localizes at or near the sarcolemma and t-tubules 
using antibody labeling of dysferlin in wild-type skeletal muscle [16, 122-124].  In 
addition to the predominant high molecular weight dysf-pHGFP protein, we also 
identified several minor lower molecular weight proteins in muscle using C-terminally 
directed antibodies to dysferlin or GFP, indicating the presence of C-terminal cleavage 
products.  A similar pattern of low molecular weight fragments of endogenous dysferlin 
were detected in wild-type muscle using a C-terminal dysferlin antibody.  C-terminal 
fragments of dysferlin containing only the terminal C2 and transmembrane domains 
have been previously shown to be present and localize at lesions in wounded human 
myotubes [125].  These findings indicate that although a minor portion of dysf-pHGFP 
detected in transgenic fibers may be present as low molecular weight C-terminal 
fragments, the presence of full-length protein and the C-terminal fragments likely 
represent endogenous dysferlin processing.  The dysf-pHGFP reporter is expressed in 
skeletal muscle at levels that are well below those previously shown to induce toxicity in 
muscle [126], and we did not observe any evidence of skeletal muscle disease in the 
dysf-pHGFP TG mice. These findings confirm that dysf-pHGFP reporter molecule is 
expressed in adult striated muscle from dysf-pHGFP TG mice, behaves similarly to wild 
type dysferlin in its processing and localization, and support a primary functional role for 
dysferlin in the sarcolemma and/or in t-tubule membranes.    
73 
 
 Dysferlin has been implicated in membrane repair, in part, due to the finding that 
it is enriched at potential membrane lesions in fixed adult skeletal muscle fibers 
following mechanical wounding [18].  Our data extend on these findings by showing with 
live-cell microscopy that dysferlin recruitment to membrane lesions occurs within 
seconds following wounding, and results in remarkably stable structures surrounding 
the lesion (that last >20 min post wounding, the longest time points measured).  
Although it has been suggested previously that the dysferlin accumulating at membrane 
wounds is derived from intracellular vesicles [18], our data showing that dysferlin is 
enriched in both the plasma membrane and the transverse tubules in resting skeletal 
muscle fibers prompted us to investigate which populations of dysferlin-containing 
membranes contribute to membrane repair in adult skeletal muscle.  Selective 
bleaching of dysf-pHGFP at the plasma membrane or t-tubules demonstrated that the 
majority of dysferlin recruited to membrane lesions is derived from the sarcolemma 
immediately adjacent to the wound, and argues against rapid fusion of pre-existing 
quenched intracellular dysferlin-containing vesicles to reseal the plasma membrane in 
adult skeletal muscle.  Our data also show that pharmacological disruption of the 
subcortical actin cytoskeleton impairs recruitment of sarcolemma-derived dysferlin at 
membrane lesions, consistent with the hypothesis that the actin cytoskeleton facilitates 
rapid recruitment of sarcolemma-derived dysferlin to membrane lesions in adult skeletal 
muscle fibers.  Previous studies in Xenopus oocytes showed that the actin cytoskeleton 
plays an active role in wound-closure by organizing contractile actin-containing “rings” 
around lesions to constrict the wound [127].  This raises the intriguing possibility that 
cortical actin may facilitate membrane repair in adult skeletal muscle by generating the 
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force required to coalesce sarcolemma-derived repair proteins at membrane lesions.  
Although cytochalasin D at similar doses does not markedly impair the organization of 
sarcomeric actin in adult isolated muscle cells [128], we cannot rule out that 
cytochalasin D may also have some effects on sarcomeric actin.  However, the 
recruitment of nearly ~30μm of dysferlin-containing sarcolemma at membrane lesions 
appears to far exceed the capacity for local sarcomere shortening.  Membrane resealing 
was directly examined to determine whether cytoskeleton-dependent recruitment of 
dysferlin to membrane lesions was required for efficient membrane repair in adult 
skeletal muscle fibers.  Increased uptake of membrane impermeant FM1-43 dye 
following laser-induced wounding is commonly used as an indicator of impaired 
membrane resealing in various cell types [18].  Under identical treatment conditions 
used to inhibit dysferlin recruitment to lesions, FM1-43 dye uptake was significantly 
increased in wild-type muscle fibers treated with cytochalasin D compared to DMSO 
control, and the magnitude of the deficit in resealing with cytochalasin D treatment is 
comparable to that observed in dysferlin-deficient muscle fibers using the same assay 
conditions.  This indicates that actin-dependent recruitment of sarcolemma-derived 
dysferlin to membrane lesions is likely critical for functional contribution of dysferlin to 
membrane resealing in adult skeletal muscle.  
Interestingly, although dysf-pHGFP fluorescent signal is elevated at membrane 
lesions, the signal from dysf-pHGFP in the distant t-tubules and sarcolemma is rapidly 
reduced after wounding, which suggests that membrane damage may also induce 
endocytosis of dysferlin into an acidic vesicular compartment.  Consistent with this 
interpretation, increasing intracellular pH in laser-wounded dysf-pHGFP TG skeletal 
75 
 
muscle fibers using NH4Cl increased dysf-pHGFP fluorescence back toward the initial 
value prior to wounding, and revealed a population of heterogeneous large cytoplasmic 
dysferlin-containing vesicles, which were not detectable in non-wounded fibers, or 
wounded fibers in the absence of NH4Cl.  These data support the overall model that 
dysferlin resides in the sarcolemma and t-tubules prior to wounding, but in regions of 
the fiber distant from the wound, is rapidly incorporated into cytoplasmic vesicles 
following membrane disruption.  Formation of wound-induced dysferlin vesicles is 
reminiscent of wound-induced vesicle formation described previously in crayfish giant 
axons following mechanical wounding [57], where endocytic vesicles accumulate and 
coalesce to form a “vesicular plug” to reseal the lesion.  Formation of large dysferlin-
containing vesicles in adult muscle fibers following laser-wounding is also consistent 
with the formation of large cytoplasmic dysferlin-containing vesicles in dysferlin-eGFP 
expressing myotubes following mechanical wounding, which result from homotypic 
fusion of dysferlin-containing vesicles, and heterotypic fusion of dysferlin-containing 
vesicles with lysosomes [120].  It is reasonable to suggest that membrane wounding 
could stimulate endocytosis of dysferlin in adult muscle fibers, as dysferlin interacts 
directly with sarcolemmal proteins that regulate endocytosis such as Caveolin-3 [52], 
and caveolin-mediated endocytosis may be activated in response to wounding in adult 
muscle fibers [89].  This finding may also explain why dysferlin is mislocalized to the 
cytoplasm in a subset of muscle fibers from patients with Duchenne muscular dystrophy 
or non-dysferlin Limb-Girdle muscular dystrophies, whose muscle fibers may be 
susceptible to sarcolemma wounding  [20].  While our data is consistent with 
endocytosis of dysferlin following wounding, we cannot completely rule out the 
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alternative hypothesis that dysferlin-containing vesicles form due to vesicularization of 
the transverse tubules, which has been described in cardiac myocytes following osmotic 
shock [129] and is consistent with the presence of several putative membrane repair 
proteins within the t-tubules [130].  Notably, photobleaching of dysf-pHGFP within the t-
tubules adjacent to the wound did not prevent the observed recruitment of dysf-pHGFP 
fluorescence at wounds; supporting our hypothesis that sarcolemma-derived dysferlin is 
the primary source of dysferlin accumulated at membrane wounds.  Whether dysferlin-
containing vesicles formed by endocytosis following wounding contribute directly to 
membrane repair in skeletal muscle is not clear at present.  Our findings that 
cytochalasin D impairs membrane resealing (as measured by FM1-43 uptake) similar to 
dysferlin deficiency, without markedly affecting dysferlin endocytosis, suggests that the 
cytoskeletal recruitment of dysferlin-containing sarcolemma to wounds is a critical 
primary step in membrane resealing resealing, and endocytosis of dysferlin may play a 
secondary role in the resealing process.   
While the use of the dysf-pHGFP reporter does not directly examine the role of 
dysferlin in resealing sarcolemmal lesions, independent biochemical studies indicate 
that dysferlin is capable of calcium-dependent lipid binding [29, 42, 91]. The findings 
reported here with the dysf-pHGFP reporter support the intriguing possibility that 
wound-induced recruitment of sarcolemma-derived dysferlin concentrates the lipid 
binding function of dysferlin at the wound, and creates an “active zone” of high calcium-
dependent phospholipid binding activity specifically at the wound, in order to facilitate 
binding or fusion of intracellular vesicles (dysferlin-containing or otherwise) with the 
sarcolemma and reseal the sarcolemma following membrane injury in adult muscle 
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cells.  In summary, using live-cell imaging to directly study dysferlin dynamics in adult 
muscle fibers, this study supports a new model that recruitment of sarcolemma-derived 
dysferlin to membrane lesions is required for membrane repair.  The dysf-pHGFP 
reporter mouse described here will also be a valuable tool to directly visualize 
sarcolemma damage in real time, examine the localization and activation of the muscle 
membrane repair pathway in other physiological models of muscle injury and muscular 
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Figure 3-1. Dysferlin-pHGFP 
transgenic reporter mouse.  A) 
Dysf-pHGFP transgene B) The 
dysf-pHGFP reporter places a pH-
sensitive pHluorin within the acidic 
lumen of vesicles or the 
extracellular face of the 
sarcolemma or transverse tubules 
C) Dysferlin-pHGFP localizes to 
the lateral membrane of skeletal 
muscle fibers in dysf-pHGFP TG 
skeletal muscle (right-panel). No 
GFP signal from wt skeletal 
muscle (left-panel).  D) Western 
blot reveals an upward shifted 
band specifically in dysf-pHGFP 
TG muscle using dysferlin 
antibody (top), and anti-GFP 
antibody (bottom).  E)  Dysferlin 
expression is increased between 
2.5 and 5-fold in transgenic 
skeletal muscle.  F) Muscles from 
dysf-pHGFP TG mice are 
comparable to wild-type muscle 
based on hematoxylin & eosin 
histological staining of 
gastrocnemius muscles from 14-
wek old mice.  G) Skeletal muscle 
from Dysf-pHGFP TG mice do not 
show an increase in centrally 
nucleated fibers (2888 fibers from 
4 WT animals and 3058 fibers 
from 3 dysf-pHGFP TG animals).  
































Figure 3-2. Dysf-pHGFP is localized at the lateral sarcolemma and striated internal 
membranes in adult skeletal muscle fibers from dysf-pHGFP TG mice similar to 
endogenous dysferlin in wild-type mice.  A) Antibody labeling of endogenous 
dysferlin shows reveals that dysferlin localizes to the lateral sarcolemma and a striated 
internal membrane compartment in adult skeletal muscle fibers. Dysf-pHGFP 
localization in transgenic muscle fibers (B, middle) is similar to endogenous dysferlin 
(compare with A) and colocalizes with total dysferlin (Romeo antibody detection of dysf-
pHGFP + endogenous dysferlin in transgenic fibers) at the lateral sarcolemma and 


































Figure 3-3. Dysferlin is highly enriched in the plasma membrane and transverse 
tubules in adult skeletal muscle fibers.  A) Dysf-pHGFP localizes to the lateral 
membrane and internal membrane structures in live FDB fibers isolated from dysf-
pHGFP TG mice.  B) Dysf-pHGFP is visible at the lateral sarcolemma and internal 
membrane structures at extracellular pH 7.4 (left panel) and pHGFP signal is 
significantly reduced following reduction of extracellular pH from pH 7.4 to pH 5.5 
(quantified in C).  D) Dysf-pHGFP is visible at the lateral sarcolemma and internal 
membrane structures (left panel) and fluorescence intensity is not increased by NH4Cl 
treatment (quantified in E).  (n=3 fibers in B and C, n= 6 fibers in D and E).  Scale bar in 


































Figure 3-4. Sarcolemma-derived dysferlin is recruited to membrane lesions 
following wounding in adult skeletal muscle fibers.  A) Dysferlin is rapidly recruited 
to membrane lesions following laser wounding in adult skeletal muscle fibers.  B) 
Quantification of dysf-pHGFP fluorescence following wounding in adult skeletal muscle 
fibers. Dysf-pHGFP fluorescence is increased at membrane lesions (red arrowheads in 
B, quantification in C) but rapidly reduced from regions of sarcolemma and transverse 
tubules not adjacent to the wound (white arrows in B, quantification in D).  E) Dysferlin 
used in membrane repair is derived from the adjacent sarcolemma in adult skeletal 
muscle fibers.  Dysferlin is uniformly distributed within the sarcolemma and t-tubules of 
a resting fiber (a).  A 30μm ROI containing sarcolemma was bleached (b), wounded in 
the center (c), and dysf-pHGFP from the lateral sarcolemma is pulled toward the wound 
and constricts the pre-bleached ROI (pre in F, and post in G) indicating that the lateral 































Figure 3-5. Membrane damage induces formation of acidic dysferlin-containing 
vesicles in adult skeletal muscle fibers.  Fluorescence intensity was quantified prior 
to wounding (Pre-lesion), one minute following wounding (post-lesion) and following 
solution change to physiological saline (PSS, A), or physiological saline + 50mM NH4Cl 
(C) to alkalinize all cellular compartments.  Treatment of wounded TG fibers with PSS 
alone had no effect on fluorescence intensity (A) and did not reveal dysferlin-containing 
vesicles in high resolution images (B), while treatment of wounded fibers with 50mM 
NH4Cl led to a significant increase in fluorescence intensity back toward baseline (C) 
and revealed the presence of large intracellular dysferlin-containing vesicles (D). (n= 6 

































Figure 3-6. Disruption of actin filaments impairs recruitment of sarcolemma-
derived dysferlin without affecting damage-induced endocytosis of dysferlin.  TG 
skeletal muscle fibers were treated with DMSO +/- 50μM cytochalasin D for 1.5 hr and 
assayed for dysf-pHGFP fluorescence changes at the lesion (A) or endocytosis of 
dysferlin (B) as well as the presence of vesicles revealed by NH4Cl treatment (A’ and 
B’).  Recruitment of dysferlin-containing membrane is significantly reduced in cells 
treated with cytochalasin D (A, quantified in C), with no effect on endocytosis (B, 
quantified in D) (DMSO n= 6 fibers, CytoD n=12 fibers).  Vesicles were detected 
following treatment with 50mM NH4Cl in both DMSO (A’) and Cytochalasin D treated 

































Figure 3-7. Disruption of the actin cytoskeleton increases FM1-43 uptake 
following membrane wounding in adult wild-type skeletal muscle fibers.  A) 
Wounding induced uptake of FM1-43 dye is increased in dysferlin-deficient muscle 
fibers from A/J compared to wild type (Quantified in B, WT n=7 fibers, Dysferlin-null n=9 
fibers).  C) Laser-wounding induced uptake of FM1-43 is increased in wild-type fibers 
pre-treated for 1.5 hr with 50μM cytochalasin D compared to DMSO treated control 






































Figure 3-8. Dysferlin localizes to the plasma membrane and transverse tubules in 
adult cardiac myocytes. A) Dysf-pHGFP is detectable as an upward shifted band in 
western blots of KCl-washed microsomes isolated from wild-type or dysf-pHGFP TG 
adult hearts using an anti-dysferlin antibody (top), or anti-GFP antibody (bottom). B) 
Fluorescence intensity from dysf-pHGFP TG cardiac myocytes is dramatically reduced 
by switching cells from extracellular pH 7.4 (left panels) to extracellular pH 5.5 (right 
panels). C) Fluorescence intensity of dysf-pHGFP TG cardiac myocytes is not affected 
































Figure 3-9. Dysf-pHGFP expression in skeletal muscle from dysf-pHGFP TG mice. 
A) Western blots using an anti-GFP show the presence of a dysf-pHGFP TG specific 
high molecular weight band corresponding to dysf-pHGFP as well as lower molecular 
weight putative C-terminal cleavage products in transgenic skeletal muscle microsomes. 
B) Western blots using NCL-hamlet antibody detect a prominent high molecular weight 
band in wild-type and transgenic skeletal muscle microsomes corresponding to 
endogenous dysferlin, as well as an upward shifted band specifically in dysf-pHGFP TG 
microsomes.  Minor lower molecular weight bands corresponding to potential cleavage 
products are detectable in transgenic skeletal muscle microsomes (left panel).  A similar 
pattern of low molecular weight endogenous C-terminal dysferlin   isoforms are visible in 


































Figure 3-10. Depletion of t-tubule GFP signal does not affect recruitment of dysf-
pHGFP at membrane lesions in transgenic skeletal muscle fibers. a) Dysf-pHGFP 
localizes to the plasma membrane and transverse tubules in adult resting skeletal 
muscle fibers. b) Dysf-pHGFP TG skeletal muscle fiber following t-tubule bleaching. c) 
Laser-wounding results in rapid and stable accumulation of dysf-pHGFP at membrane 















CONCLUSIONS AND FUTURE DIRECTIONS 
 
Summary of thesis work 
 
Dysferlin-deficiency results in a complex set of muscular dystrophies, collectively 
termed dysferlinopathies [22]. The exact cellular deficits caused by dysferlin deficiency 
that lead to muscle disease are not clear, but dysferlin is required for efficient 
membrane resealing, a critical evolutionarily conserved process by which cells repair 
the plasma membrane following wounding [18, 61]. Bansal et al first demonstrated a 
role for dysferlin in membrane resealing by showing that damage induced uptake of 
membrane impermeable FM1-43 dye is increased in muscle fibers isolated from 
dysferlin-deficient mice compared with normal control muscle fibers. Furthermore, 
electron micrographs of dysferlin-deficient muscle reveal the presence of 
subsarcolemmal vesicles near PM disruptions, indicating that dysferlin-deficiency may 
impair fusion of intracellular repair vesicles with the PM following wounding [18]. Since 
the identification of dysferlin as a critical membrane repair protein in muscle cells, 
interactions between dysferlin and several additional proteins involved in membrane 
repair have been described including MG53 [51, 52], AHNAK [100], Annexin [53, 90] 
and caveolin-3 [52]. However, the mechanism by which dysferlin-containing membranes 
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contribute to membrane resealing in normal adult muscle is not clear. Furthermore, the 
cytoskeleton has been implicated in membrane resealing in non-muscle cells [82, 83], 
but whether dysferlin-containing membranes interact with the cytoskeleton to facilitate 
membrane repair in muscle is completely unknown. Therefore, the goal of this project 
was to examine the contribution of dysferlin-containing membranes and the 
cytoskeleton to membrane repair in skeletal muscle cells. To address this, live-cell 
imaging of fluorophore-labeled dysferlin in either developing (chapter 2) or adult muscle 
cells (chapter 3), in combination with either pharmacological or genetic disruption of the 
cytoskeleton, was used to examine the dynamic behavior of dysferlin-containing 
membranes prior to and following wounding and the requirement of the cytoskeleton  for 
dysferlin-containing membrane function during membrane repair. Chapter 2 revealed 
that dysferlin-containing vesicles are capable of long-range movement along 
microtubules in differentiated L6 myotubes, and that mechanical wounding induces 
vesicle-vesicle fusion of dysferlin-containing vesicles, resulting in the formation of large 
"plug" forming cytoplasmic dysferlin-containing vesicles. Whether dysferlin is strictly 
required for vesicle-vesicle fusion following wounding is not clear, but this data, taken 
together with the proposed role for dysferlin in lipid binding in-vitro [42, 91], implicates 
dysferlin as a potential critical regulator of vesicle-vesicle fusion following wounding in 
muscle cells. Vesicle-vesicle fusion of dysferlin-containing vesicles was dependent on 
the presence of an in-tact microtubule cytoskeleton and functional KIF5B motors, which 
highlights a potential role for the microtubule cytoskeleton in membrane resealing in 
skeletal muscle myotubes. Chapter 3 expanded on the findings in chapter 2 by 
examining the behavior of dysferlin-containing membranes following laser-induced 
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membrane wounding in adult skeletal muscle fibers isolated from a novel dysferlin-
pHGFP muscle-specific transgenic reporter mouse. The pH-sensitivity of this reporter 
was used to examine the localization of dysferlin in adult muscle cells prior to and 
following laser-induced wounding. Interestingly, our data indicate that dysferlin-
expression is restricted to the sarcolemma and t-tubules in adult skeletal muscle fibers, 
with minimal dysferlin in intracellular vesicles in resting muscle fibers. Consistent with a 
role for sarcolemma derived dysferlin in membrane resealing, laser-induced wounding 
resulted in rapid and stable accumulation of adjacent dysferlin-containing sarcolemma 
at membrane lesions. Additionally, dysferlin from distant portions of the fiber is 
endocytosed into a heterogeneous population of intracellular vesicles. Pharmacological 
disruption of the actin-cytoskeleton impaired dysferlin recruitment at membrane lesions 
without affecting endocytosis, and impaired membrane resealing (based on FM1-43 
uptake). These findings support the novel model that actin-dependent recruitment of 
dysferlin-containing sarcolemma at membrane lesions may facilitate membrane repair 
by creating a local "active-zone" of high lipid binding activity to enhance fusion of 
dysferlin-containing or non-dysferlin intracellular vesicles with the plasma membrane 
and facilitate resealing. The work presented in chapters 2 and 3, and summarized below 
expand the knowledge of dysferlin-mediated membrane resealing by directly 
demonstrating a role for dysferlin-containing membranes in membrane resealing and 
highlighting a critical role for the cytoskeleton in regulating dysferlin-mediated 
membrane resealing in skeletal muscle. 
 Chapter 2 showed that dysferlin localizes to non-secretory, non-lysosomal 
cytoplasmic vesicles within the cytoplasm of L6 myotubes. Live-cell imaging of dysferlin-
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eGFP expressing myotubes revealed that the majority of dysferlin-containing vesicles 
undergo solely back and forth movements, with a small percentage undergoing long 
range movements. Long range movement of dysferlin-containing vesicles depends on 
intact microtubules, as pharmacological disruption of microtubules impairs dysferlin-
vesicle movement. Furthermore, dysferlin-containing vesicles labeled with KIF5B, 
indicating that KIF5B may be the microtubule-based motor driving movement of 
dysferlin-containing vesicles in myotubes. In order to examine the contribution of 
dysferlin-containing vesicles to membrane repair, we employed a mechanical wounding 
technique to induce local membrane lesions. Interestingly, mechanical wounding 
commonly led to complete tearing of the muscle fiber, analogous to the formation of 
"hypercontraction-clots" formed in response to isometric tetanic contractions in mdx 
muscles in-vitro [14]. Strikingly, rather than accumulate specifically at membrane 
lesions, dysferlin-containing vesicles underwent rapid vesicle-vesicle fusion to form 
extremely large dysferlin-containing vesicles throughout the cytoplasm of L6 myotubes. 
The large damage-induced vesicles formed following wounding are remarkably stable, 
and although somewhat rare, are capable of collapsing on the wounded sarcolemma. 
Formation of large cytoplasmic vesicles was reminiscent of the "vesicular plug" model of 
membrane resealing, whereby membrane wounding induces the rapid formation of 
cytoplasmic vesicles that plug the membrane lesion [59]. Given that dysferlin-containing 
vesicles interact with microtubules and KIF5B in resting myotubes, we examined 
whether these interactions were critical for large vesicle formation in response to 
wounding. Vesicle-vesicle fusion of dysferlin-containing vesicles was impaired in cells 
pre-treated with microtubule disrupting reagent nocodazole, indicating that a functional 
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association between microtubules and dysferlin-containing vesicles is critical for vesicle-
vesicle fusion following wounding. Expression of dnKIF5B significantly reduced 
formation of large dysferlin-containing vesicles following wounding without disrupting 
cytoskeletal architecture, Golgi formation or lysosomal organization, indicating that 
dnKIF5B impairs large vesicle formation by directly disrupting the function of dysferlin-
containing vesicles following wounding. These data indicate that KIF5B based 
movement along microtubules is critical for large vesicle formation following wounding in 
differentiated L6 myotubes, and support the overall model that damage-induced 
formation of large dysferlin-containing vesicles contributes to membrane resealing by 
forming a vesicular plug to repair membrane lesions. Lysosomes are critical regulators 
of membrane resealing in non-muscle cells, but whether lysosomes contribute to 
membrane resealing muscle, and whether lysosomes interact with dysferlin-containing 
vesicles has not been explored. Dual labeling of lysosomes and dysferlin-containing 
vesicles in L6 myotubes revealed that dysferlin-containing vesicles do not localize to 
lysosomes prior to wounding, but undergo heterotypic fusion with lysosomes following 
wounding to form colabeled vesicles. Although lysosomes play a role in membrane 
resealing in non-muscle cell types [72], very few studies have addressed the specific 
role of lysosomes in membrane resealing in developing or fully differentiated muscle 
cells. Furthermore, whether lysosomes interact with dysferlin-containing membranes in 
adult muscle cells requires further examination. Taken together, these finding suggest 
that lysosomes may contribute to membrane repair in muscle by interacting with 
dysferlin-containing membranes following sarcolemma damage.  
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 Chapter 3 expanded upon the findings in chapter 2 by utilizing a novel transgenic 
mouse (dysf-pHGFP TG) expressing dysferlin-pHGFP specifically in adult striated 
muscle cells. Our dysferlin-pHGFP construct places a pH-sensitive pHluorin molecule 
on the extracellular surface of muscle fibers or lumen of vesicles depending on the 
localization of dysferlin within the muscle cell. Dysferlin-pHGFP is expressed in skeletal 
muscle and heart and localizes to the lateral membrane of skeletal muscle fibers in 
dysf-pHGFP TG mice. Dysf-pHGFP TG mice are free of pathology throughout 
adulthood, indicating that dysf-pHGFP is functioning properly in-vivo. Treatment of dysf-
pHGFP TG FDB muscle fibers with acidic media significantly reduced cellular 
fluorescence, indicating that dysferlin is enriched in the sarcolemma and t-tubules of 
skeletal muscle fibers prior to membrane disruption. Furthermore, treatment with NH4Cl, 
which is commonly used to reveal pHGFP probes within acidic vesicles [118, 119], did 
not increase cellular fluorescence in resting adult muscle fibers. Taken together, these 
data support the novel hypothesis that dysferlin expression is restricted to the 
sarcolemma and t-tubules in adult muscle fibers with minimal dysferlin present in 
vesicles at rest. Membrane disruption induces rapid accumulation of local sarcolemma-
derived dysferlin at membrane lesions, with minimal recruitment of dysferlin from 
intracellular stores, indicating that dysferlin-containing membranes involved in resealing 
may actually derive from the sarcolemma. Although dysf-pHGFP accumulates at 
membrane lesions, pHGFP signal from the surrounding regions of the sarcolemma and 
t-tubules is rapidly quenched, indicating that dysferlin may be endocytosed into acidic 
compartments following wounding. Consistent with this hypothesis, addition of NH4Cl to 
wounded fibers recovered pHGFP signal back toward baseline and revealed a 
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heterogeneous population of dysferlin-containing vesicles throughout the cytoplasm of 
wounded fibers. Interestingly, myoferlin, a dysferlin homolog, is critical for endocytosis 
potentially through interacting with caveolin-1, the muscle specific isoform of which 
(caveolin-3) also interacts with dysferlin, and myoferlin-mediated endocytosis may be 
critical for membrane resealing in endothelial cells [131]. Skeletal muscle from myoferlin 
knockout mice are myopathic and have altered t-tubule morphology, a phenotype that is 
also present in dysferlin-deficient muscle [50]. Therefore, it is interesting to speculate 
that myoferlin may also play a role in membrane resealing in skeletal muscle by 
regulating damage-induced endocytosis of dysferlin. Damage-induced vesicle formation 
in adult skeletal muscle fibers was reminiscent of vesicle-vesicle fusion of dysferlin-
eGFP containing vesicles in developing myotubes described in chapter 2. It is therefore 
likely that these vesicles play a critical role in membrane repair, potentially by interacting 
with sarcolemmal-derived dysferlin at lesions to "plug" membrane lesions. However, our 
current model is limited in that vesicular dysferlin is not visible without harsh chemical 
treatments to alkinalize the cell. Therefore, the question of whether damage-induced 
vesicles contribute directly to membrane repair could be readily addressed using an 
analogous model utilizing a dysferlin reporter tagged with a non-pH sensitive reporters 
such as eGFP or mCherry. The rapid recruitment of dysferlin-containing sarcolemma 
and formation of stable dysferlin-rich structures at membrane lesions was suggestive of 
a role for the cortical actin cytoskeleton. Disruption of the actin-cytoskeleton with 
cytochalasin D impaired accumulation of dysferlin-containing sarcolemma without 
affecting endocytosis and formation of dysferlin-containing vesicles. Identical treatment 
of wild-type fibers with cytochalasin D increased uptake of FM1-43 dye following 
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wounding comparable to dysferlin-deficiency, indicating that actin-dependent 
recruitment of dysferlin-containing sarcolemma is a critical step in membrane resealing 
in skeletal muscle. These findings are consistent with recent data that the cortical actin 
cytoskeleton contributes to wound closure in drosophila larvae [84]. Although our 
pharmacological data strongly suggests that cortical actin-dependent recruitment of 
dysferlin-containing sarcolemma is critical for membrane resealing in skeletal muscle, 
examination of dysferlin-mediated membrane repair in genetic knockouts of specific 
actin isoforms would be useful in order to directly examine the role of the cortical actin 
cytoskeleton. The exact function of dysferlin downstream of actin-dependent recruitment 
to membrane lesions is not known, but in-vitro biochemical evidence indicates that 
dysferlin is involved in calcium-dependent lipid binding [42, 91] and potentially fusion of 
repair vesicles with the sarcolemma [18]. Therefore, these findings support the overall 
model that actin-dependent recruitment of dysferlin-containing sarcolemma at 
membrane lesions could facilitate membrane repair by generating an "active-zone" of 
high lipid-binding activity to enhance fusion of dysferlin-containing or non-dysferlin 
containing repair vesicles with the plasma membrane in adult skeletal muscle 
(summarized in Fig 4-1). 
 The work presented in chapters 2 and 3, and summarized above are consistent 
with a role for dysferlin-containing membranes and the cytoskeleton in membrane 
resealing in skeletal muscle. This work did, however, reveal specific differences in the 
mechanism by which dysferlin-containing membranes contribute to membrane resealing 
in myotubes versus adult terminally differentiated muscle fibers, specifically with respect 
to the localization of dysferlin in resting and wounded cells (intracellular vesicles in 
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myotubes versus sarcolemma and vesicles in adult muscle fibers). Dysferlin has been 
shown to localize to developing t-tubule system in developing C2C12 myotubes based 
on colocalization with t-tubule marker Bin-1 [49]. Given that fully developed transverse 
tubules are thought to develop from vesicular precursors in differentiating myotubes 
[132], it is possible that the dysferlin-containing vesicles in our myotube experiments 
could be t-tubule precursors, which would be consistent with the finding that dysferlin-
pHGFP is present in t-tubules in adult skeletal muscle. The apparent lack of 
sarcolemmal dysferlin and lack of enrichment of sarcolemma-derived dysferlin in our 
myotube model may actually be due to technical limitations associated with 
epifluorescence imaging, given that a smaller signal (relative to vesicular dysferlin) may 
be difficult to detect using epifluorescence. Furthermore, there are likely important 
differences in the method of wounding in our mechanically wounded myotubes 
compared with laser-induced injury in adult myofibers. This is evident based on the 
cellular response to wounding, where myotubes undergo complete hyper-contraction, 
and adult myofibers are largely stable following wounding. This implies that the 
response (accumulation of sarcolemma-derived dysferlin and formation of damage-
induced vesicles) is likely identical, but the "dose" of wounding may be much greater in 
mechanically wounded myotubes compared to laser-wounded adult myofibers. 
Regardless, the findings from myotubes and adult skeletal muscle are consistent in that 
both form large dysferlin-containing cytoplasmic vesicles following wounding. Therefore, 
these findings indicate that formation of damage-induced dysferlin containing vesicles 
and local enrichment of dysferlin-containing sarcolemma likely contribute to membrane 
resealing in skeletal muscle. The interaction between dysferlin-containing membranes 
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and the cytoskeleton is also consistent between developing myotubes and adult skeletal 
muscle. In differentiating myotubes, dysferlin-containing vesicles associated with 
microtubules, and this association was required for formation of damage-induced 
vesicles. While the requirement of microtubules for vesicle formation in adult skeletal 
muscle was not examined, it is plausible given that membrane wounding leads to 
formation of analogous dysferlin-containing vesicles in adult skeletal muscle fibers. 
Furthermore, disruption of cortical actin reduced accumulation of sarcolemma derived 
dysferlin at membrane lesions in adult skeletal muscle without affecting endocytosis and 
formation of dysferlin-containing vesicles. These findings are consistent with the 
observation that treatment with blebbistatin, a non-muscle myosin-II inhibitor, did not 
affect vesicle formation following wounding in differentiating myotubes. In conclusion, 
our data from differentiated myotubes and adult skeletal muscle fibers support the 
assertion that the cytoskeleton is a critical regulator of dysferlin-mediated membrane 
resealing in skeletal muscle.   
 
Implications and future directions 
 
Mutations in dysferlin lead to progressive muscle disease, potentially through an 
impaired ability of dysferlin-containing membranes to repair membrane lesions [18]. 
Recent studies have begun to examine interactions between dysferlin and additional 
proteins involved in membrane repair [52, 90], however, the exact mechanism by which 
dysferlin-containing membranes contribute to membrane repair in normal muscle has 
not been fully explored. We used a novel live-cell imaging approach to examine the 
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behavior of dysferlin-containing membranes and vesicles following wounding in 
developing and adult skeletal muscle. Our data provide mechanistic evidence that 
interactions between the cytoskeleton and dysferlin-containing membranes may be 
critical for membrane repair in muscle cells. A deeper mechanistic understanding of how 
the cytoskeleton contributes to membrane resealing will provide valuable insight into the 
role of the cytoskeleton in the prevention of muscle disease and reveal potential targets 
for therapeutics aimed at enhancing membrane repair in muscle diseases.  
 The finding that enrichment of dysferlin-containing sarcolemma is critical for 
membrane repair in adult skeletal muscle fibers (chapter 3) is completely novel, and 
suggests that enrichment of sarcolemma-derived lipid-binding moieties (ie. C2A domain 
of dysferlin) at membrane lesions may be necessary for membrane resealing and 
implies that a major function of dysferlin may be to facilitate interactions between the 
plasma membrane and repair vesicles in skeletal muscle fibers. These findings have 
important therapeutic implications given that therapeutics aimed at repairing the 
sarcolemma (which could conceivably treat several muscular dystrophies independent 
of genetic origin) would not need to be transported into a specific sub-cellular 
compartment, rather a compound that remained extracellular but bound lipids may be 
sufficient restore sarcolemmal integrity. Furthermore, given that gene therapy for 
dysferlin-deficiency will likely be limited by the relatively large size of dysferlin, our 
findings indicate that a simplified molecule containing the calcium-dependent lipid 
binding C2A domain targeted to the plasma membrane may be sufficient to restore 
resealing capacity in dysferlin-deficient fibers. Interestingly, this is supported by a recent 
study that identified the C2A and transmembrane domain as critical functional domains 
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required for resealing, but whether this molecule ameliorates any of the pathology in 
dysferlin-deficient mice remains to be explored [29].  
 Although the pathogenesis of DGC-related muscular dystrophies is well 
described, the underlying cellular mechanisms by which mutations in DGC components 
lead to muscle disease are largely unknown. The current dogma is that loss of DGC 
components results in an "instability" of the muscle sarcolemma and susceptibility of 
muscle fibers to contraction-induced wounding. The field is limited, however, by a lack 
of reagents to study the development of membrane lesions in muscle fibers in-vitro and 
in-vivo. Our data from chapter 3 demonstrates clearly that dysferlin robustly and 
reproducibly labels membrane lesions in adult skeletal muscle fibers. Therefore, our 
novel dysferlin-pHGFP TG reporter mouse will serve as an important tool for studying 
disruption of the plasma membrane and activation of the repair pathway in various 
models of muscle disease, including the muscular dystrophies. Therefore, the future 
studies proposed below are aimed at both identifying critical molecules that regulate the 
membrane repair pathway, as well as using the dysferlin-pHGFP TG mouse to ask 
more fundamental questions about how mutations in various muscular dystrophy 
causing genes lead to the development of muscular dystrophy. 
 
Contribution of damage-induced dysferlin-containing vesicles to membrane 
repair in adult skeletal muscle cells:  
 In chapter 3, the pH-sensitivity of dysferlin-pHGFP was used to explore the 
localization of dysferlin within adult skeletal muscle fibers at rest and following laser-
induced wounding. Our data indicate that dysferlin expression is restricted to the 
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sarcolemma and t-tubules in resting adult muscle fibers, but following wounding, 
dysferlin is rapidly endocytosed and incorporated into large cytoplasmic vesicles, 
analagous to vesicle-vesicle fusion in myotubes (chapter 2), which may contribute to 
membrane repair by plugging membrane lesions. However, examination of vesicle 
behavior is limited in our transgenic model by the fact that pHGFP is not fluorescent at 
low pH (within the lumen of endocytic vesicles), and thus vesicles are not visible without 
treatment of the fibers ammonium chloride, which may have adverse effects on vesicle 
function. In order to circumvent this limitation, an MCK driven dysferlin-mCherry 
transgenic mouse could be generated, which will express constitutively fluorescent 
mCherry reporter gene to track the dynamic response of newly formed dysferlin-
containing vesicles in live adult skeletal muscle cells following wounding (Fig 4-2A). 
Therefore, subjecting adult skeletal muscle fibers isolated from dysf-mCh TG mice to 
laser wounding and analyzing vesicle formation and accumulation at membrane lesions 
could be used to the hypothesis that damage-induced dysferlin-containing vesicles 
contribute to membrane resealing in adult skeletal muscle (Fig 4-2B). 
 Our data from dysf-pHGFP TG skeletal muscle fibers indicates that sarcolemma-
derived dysferlin accumulates at membrane lesions and forms stable patches, but 
whether damage-induced dysferlin-containing vesicles accumulate with sarcolemma 
derived dysferlin at membrane lesions is not clear (as any endocytic dysferlin cannot be 
detected). Therefore, crossing the constitutively fluorescent dysf-mCh reporter mouse to 
the dysf-pHGFP TG mouse presented in Chapter 3 to generate a dysf-mCh/pHGFP 
double transgenic mouse will generate a muscle specific transgenic that expresses both 
a pH-sensitive GFP reporter as well as a constitutively fluorescent mCh reporter within 
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all muscle cells (Fig 4-2C). This model will allow for the simultaneous analysis of 
sarcolemma-localized dysferlin, (both green and red), and vesicular dysferlin (red but 
not green) at nascent lesions in adult skeletal muscle fibers. The ratio of green:red 
fluorescence (normalized for maximal intensity) at membrane lesions would 
hypothetically serve as an indicator of the relative percentage of vesicular dysferlin 
within nascent patches. Thus, a perfect 1:1 green:red intensity ratio within nascent 
patches would indicate that all dysferlin within the patch is within the sarcolemma, 
whereas values <1:1 would indicate that a portion of dysferlin within the nascent patch 
is derived from dysferlin present within endocytic vesicles (potential outcomes 
presented in Fig 4-2D). An additional dysf-eGFP/dysf-mCh transgenic mouse 
expressing constitutively fluorescent green and red probes could be generated, and 
skeletal muscle fibers isolated from this mouse could be used as a control that is 
constitutively 1:1 green to red. While the data presented in chapters 2 and 3 supports 
our current model (Fig 4-1), the proposed experiments would provide strong evidence 
that damage-induced dysferlin-containing vesicles contribute to membrane repair in 
adult skeletal muscle. 
  
Endocytosis, and myoferlin as a critical regulator of dysferlin-mediated 
membrane repair in adult skeletal muscle:  
 The novel finding that membrane damage induces the formation of dysferlin-
containing vesicles in skeletal muscle raises intriguing questions about the role of 
endocytosis in membrane resealing in adult skeletal muscle. Initial reports on 
membrane resealing in adult skeletal muscle overlooked endocytosis as a potential 
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regulator of membrane repair because of the apparent lack of caveolin-3 (a plasma 
membrane protein with a known role in endocytosis) at membrane lesions in 
mechanically wounded adult skeletal muscle fibers [18]. However, recent data suggests 
that caveolin-mediated endocytosis is activated in close proximity to membrane lesions 
leading to formation of caveolin-containing vesicles near membrane lesions, which 
implies that endocytic vesicles may contribute to membrane repair[89]. Furthermore, 
there are several lines of evidence that endocytosis contributes to membrane resealing 
in non-muscle cell types [56, 57, 89]. In neurons, axotomy induces rapid formation and 
accumulation of endocytic vesicles near the proximal cut end, and these endocytic 
vesicles form a semi-permeable barrier that rapidly excludes extracellular dyes [56]. In 
CHO cells, membrane lesions induced by SLO-toxin (which forms transmembrane 
pores within the plasma membrane) are rapidly endocytosed into caveolin-containing 
vesicles, a process that is required for resealing the plasma membrane [62]. 
Furthermore, enzyme release as a result of lysosomal exocytosis may facilitate 
endocytosis at membrane lesions, a process which contributes to membrane repair in 
NRK cells [78]. Despite growing evidence that endocytosis contributes to membrane 
repair in non-muscle cells, there have been few studies examining the role of 
endocytosis in membrane repair in adult skeletal muscle. 
 Myoferlin, a homolog of dysferlin, is highly expressed in developing cardiac and 
skeletal muscle and is expressed to somewhat lower levels in adult skeletal and cardiac 
muscle. Loss of myoferlin expression in mice results in an early-onset muscle myopathy 
with the most prominent phenotype being impaired cell-cell fusion during myogenesis, a 
phenotype which has also been reported for dysferlin-deficient muscle cells in-vitro and 
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in-vivo. Double knockout of myoferlin and dysferlin enhances the dysferlin-deficient 
phenotype, and deficiency of dysferlin, myoferlin, or both results in alterations in t-tubule 
morphology, suggesting that both myoferlin and dysferlin contribute to t-tubule stability 
or maintenance in skeletal muscle. Perhaps most intriguingly, membrane repair capacity 
is impaired in myoferlin-deficient endothelial cells [131] and over-expression of myoferlin 
may enhance membrane repair in dysferlin-deficient skeletal muscle [133]. Although the 
exact role for myoferlin in membrane resealing is not known, it is reasonable to suspect 
that myoferlin may contribute to membrane resealing by regulating damage-induced 
endocytosis. Surprisingly, there have been no studies addressing whether myoferlin is 
required for membrane resealing in adult skeletal muscle fibers, nor have there been 
any studies addressing the effect of myoferlin-deficiency on dysferlin function in 
membrane repair. Our data suggests that membrane damage induces rapid 
endocytosis of dysferlin into cytoplasmic vesicles, which may be critical for membrane 
resealing. Therefore, it is reasonable that myoferlin may contribute to membrane 
resealing in skeletal muscle by facilitating endocytosis of dysferlin into dysferlin-
containing vesicles for subsequent use in membrane repair (Fig 4-3A). 
 Our data from chapter 3 suggests that skeletal muscle fibers from dysf-pHGFP 
TG mice can be used to track the endocytosis of dysferlin from the plasma membrane 
following wounding, providing a straightforward assay to assess endocytosis of dysferlin 
following wounding. Crossing the dysf-pH TG mouse described in chapter 3 to a 
myoferlin KO mouse to generate a mouse expressing dysf-pHGFP on a myoferlin-null 
background (myofKO pHGFP TG) mouse could be used to directly test the hypothesis 
that myoferlin is required for endocytosis of dysferlin following membrane damage in 
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adult skeletal muscle fibers. To test this hypothesis, muscle fibers could be isolated 
from myofKO TG mice and wild-type TG controls, subjected to our laser wounding 
assay, and analyzed for the pHGFP response to wounding (Fig 4-3C). If myoferlin is 
required for endocytosis of dysferlin following wounding, then the rapid decrease in 
"total" pHGFP fluorescence would be reduced in myofKO pHGFP TG skeletal muscle 
fibers following wounding. Crossing the aforementioned dysferlin-mCh transgenic 
mouse to a myofKO mouse to generate a myofKO mChTG mouse would avoid the 
limitations associated with pHGFP (outlined previously) and allow for direct examination 
of dysferlin vesicle formation, and behavior of damage-induced dysferlin-containing 
vesicles following wounding in myoferlin-null muscle fibers (Fig 4-3D). Finally, FM1-43 
uptake following laser induced wounding in myofKO and wild-type adult muscle fibers 
could be examined to determine whether myoferlin is required for membrane resealing 
in muscle (Fig 4-3B).  
 Dysferlin and myoferlin share high structural homology (Fig 1-1), as well as lipid 
binding/fusion properties in-vitro [42]. Dysferlin has been shown to dimerize in-vitro and 
in live-cells [134], which raises the possibility that myoferlin-dysferlin heterodimerization 
could occur. Such an interaction could efficiently couple endocytosis and plug formation 
at membrane lesions. This hypothesis could be tested biochemically by expressing 
epitope tagged dysferlin and myoferlin constructs and using co-immunoprecipitation 
followed by western blotting. Additionally, the in-vivo relevance of these interactions 
could be directly examined using FRET-based imaging of acutely transfected myotubes 
expressing fluorophore labeled myoferlin and dysferlin constructs, as has been used 





Regulation of dysferlin-mediated membrane repair by cortical actin in adult 
skeletal muscle:  
In chapter 3, the contribution of sarcolemma-derived dysferlin to membrane 
repair in adult skeletal muscle was examined, which revealed that local dysferlin-
containing sarcolemma is actively pulled into membrane lesions, resulting in the 
formation of a stable dysferlin-rich structure at membrane lesions. Based on the rapid 
and stable nature of nascent dysferlin-containing structures, it was proposed that the 
actin-cytoskeleton could play a critical role in recruitment of dysferlin-containing 
sarcolemma to membrane lesions. Pharmacological disruption of the actin-cytoskeleton 
significantly reduced dysf-pHGFP accumulation at membrane lesions, indicating that the 
actin cytoskeleton is critical for dysferlin-recruitment at membrane lesions and 
potentially resealing in adult skeletal muscle fibers. These findings are consistent with a 
growing body of evidence in single celled drosophila larvae and xenopus oocytes [84, 
86], which indicates that the cortical actin cytoskeleton is a critical regulator of 
membrane repair. In the drosophila model, membrane damage induces the formation of 
a "contractile ring" composed of F-actin and non-muscle myosin II (nmII) which 
contracts to pull both the PM and intracellular vesicles into a repair plug [84]. 
Furthermore, it was recently shown that putative repair protein MG53 is actively 
transported to membrane lesions in an non-muscle myosin II (nmII) dependent manner, 
and pharmacological inhibition of nmII impaired membrane resealing in adult skeletal 
muscle [67]. Although our data supports a role for cortical actin  in dysferlin-mediated 
106 
 
membrane resealing in skeletal muscle, our ability to selectively disrupt the cortical actin 
cytoskeleton is limited by the fact that cytochalasin D is not necessarily specific for 
cortical actin. Therefore, examination of genetic mutants for specific cortical actin 
isoforms could be useful in determining the precise molecular components of the 
cytoskeleton required for membrane repair in muscle. 
Three major isoforms of actin are expressed in adult skeletal muscle, and which 
specific isoform is critical for membrane repair remains an open question [135]. The α-
skeletal actin isoform is a major component of the thin filament of the contractile 
sarcomere, and regulates force production through direct interactions with the myosin 
containing thick filament [135]. β- and γ-actin are the major a components of the sub-
sarcolemmal actin cortex and knockout of either gene results in progressive muscle 
myopathy [136, 137]. β-actin deletion results in decreased dystrophin expression and 
susceptibility to eccentric contraction, consistent with the primary deficits associated 
with impaired DGC function [136]. In contrast, γ-actin knockouts display a skeletal 
muscle myopathy independently of any effects on the DGC, and do not display 
susceptibility to eccentric contraction or impaired sarcolemmal integrity at rest, 
consistent with the effects of dysferlin-deficiency on muscle function [137]. Furthermore, 
γ-actin expression is increased in dystrophin-deficient muscle and may protect 
dystrophin-muscle from contraction induced damage [138, 139]. Our data indicates that 
disruption of either γ or β actin may result in impaired accumulation of dysferlin-
containing membrane at membrane lesions, as well as membrane resealing in adult 
skeletal muscle fibers. Although γ-actin deficiency does not recapitulate the exact 
phenotype of dysferlin-null mice (ie. high CK), the development of myopathy in the 
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absence of DGC defects, relative insensitivity to lengthening contraction, and mild 
sarcolemmal permeability at rest suggest that the loss of γ-actin may result in muscle 
disease in part through impaired membrane repair [137]. Therefore, it is likely that γ-
actin may be a critical regulator of dysferlin-mediated membrane resealing in adult 
skeletal muscle fibers.  
The role of γ-actin in dysferlin-mediated membrane repair could be directly 
assessed by crossing our dysf-pHGFP TG mouse with muscle-specific γ-actin KO mice 
to generate a dysf-pHGFP TG mouse on a γ-actin deficient background  (γ-KOpHGFP 
TG ) and subjecting dysf-pHGFP TG and γ-KOpHGFP TG muscle fibers to laser-
wounding (Fig 4-4C). Based on our findings in chapter 3, it would be predicted that 
accumulation of sarcolemmal dysferlin would be markedly reduced in γ-KOpHGFP TG 
muscle fibers compared to wt-TG control. Examination of total cellular fluorescence 
following wounding in wt-TG and γ-KOpHGFP TG could be used to examine the effect 
of γ-actin deficiency on dysferlin endocytosis and formation of dysferlin-containing 
vesicles following wounding. Although our data indicates that endocytosis of dysferlin 
and formation of damage-induced dysferlin-containing vesicles is not affected by 
pharmacological disruption of the actin cytoskeleton, our data does not rule out whether 
cytoskeletal actin (γ-actin) regulates any downstream functions of dysferlin-containing 
vesicles such as accumulation of dysferlin-containing vesicles at membrane lesions in 
adult skeletal muscle fibers. Crossing γ-KO mice to the dysf-mCh transgenic described 
above would generate a constitutively fluorescent dysferlin reporter on a γ-actin 
deficient background (γ-KOmCh TG). This model could then be used to examine the 
behavior of damage-induced dysferlin-containing vesicles following membrane 
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disruption in live adult skeletal muscle fibers (Fig 4-4D). If γ-actin is required for 
accumulation of dysferlin-containing vesicles, one would expect that the γ-KOmCh TG 
fibers would show reduced vesicle accumulation at membrane lesions compared with 
the mChTG control. FM1-43 uptake following laser induced wounding in wt and γ-KO 
muscle fibers could be used to determine whether γ-actin and γ-actin-dependent 
recruitment of dysferlin-containing sarcolemma at membrane lesions is required for 
membrane resealing in adult skeletal muscle fibers (Fig 4-4B). Although the data 
presented in chapter 3 supports the overall model that the cortical actin cytoskeleton is 
critical for membrane resealing in adult skeletal muscle, the proposed experiments 
would provide strong evidence that the cortical actin cytoskeleton, and specifically γ-
actin, is required for membrane resealing in adult skeletal muscle. 
 
Interaction of lysosomes and dysferlin-containing membranes and role of 
lysosomes in membrane repair in skeletal muscle: 
 Although much of our work was devoted to investigating the behavior of dysferlin-
containing membranes during membrane repair, the previously identified role for 
lysosomes in membrane resealing in non-muscle cell types led us to examine the 
interaction between dysferlin-containing vesicles and lysosomes in skeletal muscle cells 
[72]. This question was examined by simultaneously tracking the localization and 
behavior of dysferlin-containing vesicles (dysferlin-eGFP) and lysosomes (LGP120-
mCh) in differentiated myotubes prior to and following mechanical wounding. Our data 
indicates that dysferlin-containing vesicles are distinct from lysosomes in resting cells, 
but undergo heterotypic fusion following membrane damage. These data indicate that 
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heterotypic fusion of dysferlin-containing vesicles with lysosomes maybe critical for 
membrane repair in skeletal muscle. Given the strong appreciation for lysosomal 
function in membrane resealing in non-muscle cells [72], the role of lysosomes 
membrane resealing and the relationship between lysosomes and dysferlin-containing 
membranes in adult muscle cells warrants further examination.    
 Our findings from chapter 2 support a potential role for lysosomes in membrane 
resealing in developing myotubes, but a role for lysosomes in membrane repair in adult 
muscle fibers remains to be demonstrated. Given that most proteins or organelles 
involved in membrane resealing accumulate at membrane lesions following wounding 
[18, 51, 90], an examination of lysosomal behavior following wounding in live adult 
skeletal muscle cells using commercially available dyes such as lysotracker, antibody 
labeling of endogenous proteins (Lamp-1) or expression of genetic labels (LGP120-
mCh) in adult muscle fibers following laser-induced may be informative. FM1-43 uptake 
in wild-type adult skeletal muscle fibers treated with pharmacological inhibitors of 
lysosome function, such as GPN [140], could be used to explore the effect of 
pharmacological disruption of lysosomal function on membrane resealing in adult 
skeletal muscle fibers. Synaptotagmin-VII is a critical regulator of lysosomal exocytosis 
and function [141], and fibroblasts isolated from syt-VII knockout mice display impaired 
membrane resealing [71]. At the molecular level, dysferlin is highly homologous to syt-
VII, but whether syt-VII is required for membrane resealing in muscle cells is not known. 
Examination of membrane resealing could be carried out in primary myotubes or adult 
skeletal muscle fibers isolated from sytVII-KO mice. If lysosomes are required for 
membrane resealing in adult skeletal muscle, then both pharmacological and genetic 
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inhibition of lysosomal function (syt-VII deficiency) should increase uptake of FM1-43 
following wounding.  
 If syt-VII KO muscle fibers show a defect in membrane resealing, one potential 
explanation could be that loss of syt-VII on lysosomes impairs damage-induced fusion 
of lysosomes with dysferlin-containing vesicles following wounding. This could be tested 
by analyzing the behavior of dysferlin-containing vesicles and lysosomes following 
wounding in myoblasts derived from syt-VII knockout mice acutely transfected with 
dysferlin-eGFP and LGP120 (similar to chapter 2). If syt-VII on lysosomes is required for 
the interaction between dysferlin-containing vesicles and lysosomes, then formation of 
co-labeled vesicles following wounding would be reduced. If dysferlin-containing 
membranes and syt-VII containing lysosomes are required for membrane resealing in 
muscle cells, it would be interesting to examine whether there is functional redundancy 
between these compartments in membrane resealing in skeletal muscle. Our data from 
chapter 2 indicates that lysosomes may contribute to membrane resealing by fusing 
with dysferlin-containing vesicles, however, it is also possible that syt-VII containing 
lysosomes also serve dysferlin-independent role in membrane resealing. To address 
this, adult muscle fibers isolated from dysferlin-null mice could be treated with 
pharmacological inhibitors of lysosomal function, and assayed for FM1-43 uptake 
following wounding. If lysosomes contribute to membrane resealing independently of 
dysferlin, then pharmacological inhibition of lysosome function should impair membrane 
resealing to a greater degree than dysferlin-deficiency alone. Alternatively, if inhibition of 
lysosomal function in dysferlin-deficient muscle fibers does not further impair membrane 
resealing, it could be concluded that the function of lysosomes in membrane resealing is 
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entirely dependent on dysferlin in adult skeletal muscle. Furthermore, crossing dysferlin-
deficient (A/J mice) to syt-VII KO mice to generate DKO mice would be especially 
useful, as the effect of combined loss of dysferlin and syt-VII could be examined in-vivo 
by analyzing H&E stain of skeletal muscle, plasma creatine kinase, central nucleated 
fibers, and Evan's blue dye uptake. If the muscle phenotype in DKO mice is worse than 
dysferlin-deficient mice, comparison of FM1-43 uptake in skeletal muscle fibers isolated 
from dysf-KO, syt-VII KO and DKO mice could be used to assess whether the effect of 
combined deficiency of dysferlin and syt-VII on the disease phenotype is due to further 
impaired resealing capacity when both dysferlin and syt-VII are absent.  
 
Plasma membrane instability and wounding as a common mechanism in the 
development of muscular dystrophy: 
The exact cellular mechanism by which loss of DGC or DGC-associated proteins result 
in muscular dystrophy is unclear and remains a critical question to be addressed in the 
field of muscular dystrophy. It is well known that skeletal muscle fibers from dystrophic 
human patients and mouse models of muscular dystrophy take up endogenous 
membrane impermeable molecules such as immunoglobulin (IgG, IgM) or exogenous 
membrane impermeant molecules such as Evan's blue dye from the blood stream [142, 
143]. Further, dystrophic muscles release the cytosolic muscle enzyme creatine kinase 
(CK) into the blood stream, which is commonly used as an indication of dystrophic 
pathology [2]. These data indicate that reduced sarcolemma stability or increased 
permeability may be a common pathway by which mutations in the DGC or DGC-related 
proteins result in muscular dystrophy. Based on these findings, a model has been 
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proposed suggesting that the loss of DGC components renders the plasma membrane 
"unstable" and thus susceptible to contraction induced injury in the form of 
"microlesions" to the plasma membrane. Consistent with this hypothesis, sarcolemmal 
permeability to Evan's blue dye is elevated particularly following exercise in several 
mouse models of muscular dystrophy [13, 18]. However, there are several remaining 
questions as to the types of sarcolemmal lesions that occur in skeletal muscle as a 
result of contraction-induced injury in dystrophic skeletal muscles. Although all fibers 
from DGC-deficient muscles lack functional DGC, uptake of EBD is not uniform and 
typically occurs in discrete foci containing several muscle fibers, which seems to 
suggest that only a subset of muscle fibers show increased permeability as a result of 
membrane wounding [142, 143]. Furthermore, there is little direct evidence that small 
sarcolemmal lesions occur as a result of contraction in dystrophic skeletal muscle fibers. 
In fact, Brooks and Claflin 2008 showed that lesions generated in dystrophic muscle 
following tetanic isometric contraction consisted of calcium-dependent tearing of muscle 
fibers and formation of a "contraction clot" which suggests that wounds occuring as a 
result of DGC-deficiency may actually be more catastrophic than previously proposed 
[14]. Although this study implies that in dystrophic muscle, contraction leads to rupture 
of the sarcolemma or increased leakiness of the sarcolemma, over-activation of the 
local sarcomeres due to calcium influx, and subsequent failure of the muscle fiber, the 
development of sarcolemmal lesions as a result of contraction-induced injury in 
dystrophic muscle fibers remains to be demonstrated. It is interesting to note that some 
muscular dystrophy models develop a dystrophic phenotype independent of changes in 
skeletal muscle membrane permeability. For example, laminin (the extracellular 
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receptor for dystroglycan within the basal lamina), considered a critical component of 
the DGC, results in a muscular dystrophy phenotype without an increase in skeletal 
muscle EBD uptake [143]. Furthermore, dysferlin-deficient mice display a myopathic 
phenotype with robust CK elevation, even in the absence of considerable EBD uptake 
(compared to the mdx mouse) [18]. More recently, several laboratories have questioned 
whether sarcolemmal wounds contribute to development of muscular dystrophy entirely. 
In this alternative model, stretch-induced calcium channels present on the muscle 
sarcolemma are increased in mdx skeletal muscle and enhanced stretch-induced 
calcium influx activates secondary calcium-dependent degredative pathways that 
contribute to disease progression [144]. This model is supported by findings that 
pharmacological inhibition of these channels with streptomycin, a stretch-induced 
calcium channel blocker, partially protects mdx muscles from eccentric contractions in-
vitro and following eccentric exercise in-vivo and reduces exercise-induced dye uptake 
into mdx skeletal muscle fibers following eccentric exercise in-vivo [144]. Furthermore, 
long-term in-vivo administration of streptomycin into mdx mice reduced dystrophic 
pathology and decreased EBD uptake into mdx tibialis anterior muscles, indicating that 
calcium-influx through stretch activated calcium channels may have deleterious effects 
on mdx skeletal muscle [145]. Therefore, a closer examination of sarcolemma wounding 
in dystrophic skeletal muscle following contraction in-vitro and following exercise or 
contraction in-vivo is critical for understanding the effects of DGC mutations on plasma 
membrane homeostasis and understanding the contribution of sarcolemmal wounding 
to the development of muscular dystrophy.  
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 Our dysf-pHGFP TG mouse is ideally suited to address this question, as we have 
shown (chapter 3) that dysf-pHGFP robustly and reproducibly identifies lesions in the 
plasma membrane in adult skeletal muscle fibers following wounding. Therefore, 
crossing the dysf-pHGFP TG (heretofore referred to as simply WT-TG) mouse to 
various models of muscular dystrophy including the mdx (dystrophin-deficient) and 
dy/dy (laminin-deficient) [146] and alpha-sarcoglycan [147] deficient mice (heretofore 
referred to as simply "dystrophic" or "DGC-deficient") would generate useful (mdx-TG, 
dy-TG, aSG-TG, heretofore referred to as "DGC-deficient TG") reporter mice to 
examine whether sarcolemmal lesions develop as a result of contraction in skeletal 
muscles from several independent DGC-deficient mouse models and facilitate direct 
comparison of membrane defects in each model. Adult skeletal muscle fibers could be 
subjected to contraction in-vitro and simultaneously analyzed for the formation of 
sarcolemmal lesions (similar to those shown in chapter 3) using live-cell microscopy. 
Given that dysf-pHGFP is an indirect measure of sarcolemmal permeability, 
simultaneous analysis of contraction-induced uptake of extracellular dyes or intracellular 
calcium using a calcium reporter dye could be useful. While isometric contraction is 
capable of generating muscle damage in dystrophic muscle [14], dystrophic muscle also 
shows a marked susceptibility to "lengthening", or "eccentric" contractions [116]. 
Therefore, direct analysis of contraction-induced sarcolemmal lesions developed in 
response to isometric and eccentric contractions could be useful to explore whether 
more injurious eccentric contractions are associated with increased incidence of 
sarcolemmal wounds. Based on the model from Brooks and Claflin 2008, it would be 
predicted that small sarcolemmal lesions developed following contraction contribute to 
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elevations in intracellular calcium, "over-activation" and failure of the local cytoskeleton, 
and fiber "hyper-contraction" [14]. Thus, it would be predicted that the formation of 
sarcolemmal lesions would also precede fiber hypercontraction, as well as any 
decrements in force production following eccentric contraction in DGC-deficient skeletal 
muscle fibers. This could be directly tested in this model by examining the formation of 
dysf-pHGFP patches following each contraction, and measuring maximal force 
produced by the muscle fiber following each successive contraction. Furthermore, 
treatment of WT-TG and mdx-TG muscle fibers (which have been suggested to have 
increased levels of strecth-activated channels) with streptomycin and subsequent 
analysis of lesion formation following contraction could be used to analyze the 
contribution of stretch-activated channel-dependent calcium influx to the development of 
membrane lesions. If the prevalence of membrane lesions increases with contraction 
(based on dysf-pHGFP accumulation and calcium indicator fluorescence increases), 
and the development of lesions is not affected by the presence of streptomycin, then it 
can concluded that contraction leads to sarcolemmal disruption in dystrophic models 
likely due to impaired sarcolemmal stability, and not as a secondary consequence of 
increased stretch-induced calcium channel activation.  
 In addition to in-vitro analysis of sarcolemmal wounding, these models would 
also serve as useful tools to explore the development of sarcolemmal lesions in 
dystrophic muscle in-vivo. It has been assumed that prevalence of sarcolemmal rupture 
increases in dystrophic muscle following exercise due to the finding that CK is elevated 
in dystrophic muscle and EBD uptake into skeletal muscle from dystrophic mice 
increases following exercise [13], but direct examination of membrane lesions in 
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skeletal muscle following exercise in-vivo has not been definitively shown. Therefore, 
the presence of sarcolemmal lesions (dysf-pHGFP accumulation) could be examined in 
longitudinal sections of skeletal muscle from WT-TG mice compared with DGC-deficient 
TG mice with or without treadmill exercise. Alternatively, development of sarcolemmal 
lesions could be analyzed in skeletal muscles subjected to in-situ lengthening 
contraction protocols which would allow examination of "injured" versus "non-injured" 
muscles from individual mice within each genotype. If the number of sarcolemmal 
lesions increases in DGC-deficient muscle fibers following exercise or lengthening 
contraction to a greater extent than in normal skeletal muscle, it could be concluded that 
development of sarcolemmal wounds following contraction may be a common 
mechanism by which disruption of the DGC leads to the development of muscular 
dystrophy. It is unclear whether muscle fibers in dystrophic muscle take up EBD as a 
result of small sarcolemmal lesions or whether EBD labels a more catastrophic injury 
such as muscle fibers undergoing a "hyper-contraction clot". Further, whether EBD 
positive fibers are the only fibers that have undergone sarcolemmal lesions, or whether 
formation of small sarcolemmal injuries precedes EBD uptake has not been explored. 
Therefore, analysis of exercise-induced sarcolemmal lesions in WT-TG and DGC-
deficient TG mice injected with EBD could be used to examine the relationship between 
the development of sarcolemmal lesions and the uptake of EBD in-vivo. These findings 
will have important implications given that uptake of EBD does not appear to be uniform 
throughout dystrophic muscles [142], and does not occur in skeletal muscle from all 
models of muscular dystrophy [18, 143]. Thus, an understanding of whether 
sarcolemmal lesions occur in the absence of EBD uptake may shed light on the 
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relationship between sarcolemmal wounds and EBD uptake and whether EBD uptake 
should be used as the sole indicator to identify membrane instability in novel mouse 
models with a suspected muscular dystrophy phenotype.  
 A deeper understanding of how sarcolemmal lesions develop in-vivo across a 
variety of muscular dystrophies is a critical question, as the development of 
sarcolemmal wounds has been proposed as a unifying mechanism for the development 
of muscular dystrophy, but has not been directly examined. If development of 
sarcolemmal lesions is a critical pathway by which genetic mutations lead to muscular 
dystrophy, then development of therapeutics aimed at protecting the sarcolemma from 
injury or restoring plasma membrane integrity following wounding could be an effective 
therapeutic approach. The studies outlined above would directly examine for the first 
time whether the development of sarcolemmal lesions following contraction-induced 
injury is a common occurrence in dystrophic muscle, and would lead to a deeper 




Membrane resealing is an evolutionarily conserved process by which cells repair even 
the most severe wounds in the plasma membrane. Impaired membrane resealing 
results in muscle disease [18, 52], which makes enhancement of membrane resealing 
an attractive therapeutic target [95]. However, the mechanism by which the sarcolemma 
is resealed in normal muscle is largely unknown. The goal of our study was to examine 
the behavior of dysferlin-containing membranes following wounding in skeletal muscle, 
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and determine the contribution of the cytoskeleton to dysferlin-mediated membrane 
repair in skeletal muscle. Our data support the novel model that recruitment of 
sarcolemma-derived dysferlin and formation of damage-induced vesicles contribute 
contribute to membrane repair in skeletal muscle, and demonstrate for the first time, 
that dynamic interactions between dysferlin-containing membranes and the 
cytoskeleton are critical for membrane repair in adult skeletal muscle. In addition to the 
mechanistic analysis of membrane repair in skeletal muscle, our novel dysf-pHGFP TG 
mouse model will serve as a useful tool to examine membrane wounding and activation 
of membrane repair in diseases of skeletal muscle, including the muscular dystrophies. 
Our data provide important mechanistic evidence that will serve as the basis for 
understanding dysferlin-mediated membrane resealing, and the development of novel 































Figure 4-1. Proposed model for membrane resealing in skeletal muscle cells.  
A) Dysferlin localizes to the plasma membrane and transverse tubules in resting striated 
muscle cells. B) After wounding, cortical actin (red) pulls adjacent dysferlin containing 
sarcolemma toward membrane lesions (arrows), constricting the size of the wound. 
Simultaneously, dysferlin from distal portions of the fiber is endocytosed into dysferlin-
containing vesicles. C) Dysferlin-containing vesicles undergo vesicle-vesicle fusion on 
microtubules (blue) to form large dysferlin-containing vesicles that "plug" the lesion via 






Figure 4-2. Contribution of dysferlin-containing vesicles to membrane resealing in 
adult skeletal muscle. A) Proposed model to examine the contribution of damage-
induced dysferlin-containing vesicles to membrane repair in adult skeletal muscle. Dysf-
mCherry is constitutively fluorescent, and will reveal all dysferlin populations at nascent 
patches. Dysf-pHGFP is not fluorescent within acidic vesicles. The combination of both 
labels will provide relative estimate of dysferlin at the PM (red and green) and dysferlin 
only in vesicles (red alone). B) Laser wounding of dysf-mCH TG fibers will be used to 
examine vesicle behavior. C) Crosses between Dysf-mCh and Dysf-pHGFP (left) and 
Dysf-mCh and Dysf-eGFP (right). D) Potential outcomes of laser wounding experiments 
outlined in C. If dysferlin-containing vesicles contribute to patch formation, relative 





Figure 4-3. Potential role for myoferlin in damage-induced endocytosis of 
dysferlin and membrane repair in adult skeletal muscle cells. A) Simplified 
schematic of the role for myoferlin in damage-induced endocytosis of dysferlin following 
wounding in adult skeletal muscle fibers. B) FM1-43 dye uptake assay could be used to 
assess membrane resealing in isolated myof-KO skeletal muscle fibers. C) Genetic 
cross of myof-KO and dysf-pHGFP mice to examine endocytosis of dysferlin in 
myoferlin-deficient muscle. D) Genetic cross of myof-KO and dysf-mCh to examine the 








Figure 4-4. Proposed role for gamma actin in damage-induced recruitment of 
sarcolemmal dysferlin and membrane resealing adult skeletal muscle fibers. A) 
Simplified schematic of the role for gamma actin in damage-induced patch-formation 
following wounding in adult skeletal muscle fibers. B) FM1-43 dye uptake assay could 
be used to assess membrane resealing in isolated gamma actin deficient skeletal 
muscle fibers. C) Genetic cross of gamma actin-KO and dysf-pHGFP mice to examine 
endocytosis of dysferlin in gamma actin-deficient muscle. D) Genetic cross of gamma 
actin-KO and dysf-mCh to examine the formation of dysferlin-containing vesicles 
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